desc,gpt4
diagnostic endocrine procedures,0.5
"debridement of wound, infection or burn",0.2
destruction of lesion of retina and choroid,0.75
other non-or therapeutic procedures on skin and breast,0.1
hemodialysis,0.2
peritoneal dialysis,0.25
pancreatic islet cell ab,0.85
c peptide,0.75
glucose,0.75
fructosamine,0.75
proinsulin,0.75
islet cell 512 ab,0.75
insulin,0.9
acetone,0.75
insulin ab,0.9
beta hydroxybutyrate,0.75
glucose (poc) (group:glu-poc),0.75
herpes simplex,0.0
human immunodeficiency virus [hiv] disease,0.0
dermatophytosis / dermatomycosis,0.1
dermatophytosis,0.1
dermatophytosis of nail,0.1
screening for malignant neoplasms of the skin,0.0
graves' disease,0.2
diabetes mellitus,0.75
type 1 diabetes,1.0
type 2 diabetes,0.0
type 2 diabetes with ketoacidosis,0.2
type 2 diabetes with neurological manifestations,0.0
insulin pump user,0.9
abnormal glucose,0.75
other abnormal glucose,0.5
other disorders of pancreatic internal secretion,0.75
hypoglycemia,0.75
proteinuria,0.6
hyperglyceridemia,0.3
hyperpotassemia,0.2
other disorders of metabolism,0.2
obesity,0.2
other anemias,0.2
major depressive disorder,0.2
tobacco use disorder,0.1
other retinal disorders,0.75
other nondiabetic retinopathy,0.25
glaucoma,0.2
cataract,0.35
hypertension,0.2
essential hypertension,0.2
hypertensive heart and/or renal disease,0.2
acute pancreatitis,0.2
nephritis and nephropathy without mention of glomerulonephritis,0.75
nephritis and nephropathy in diseases classified elsewhere,0.75
chronic renal failure [ckd],0.75
end stage renal disease,0.75
"chronic kidney disease, stage iii",0.75
"chronic kidney disease, stage iv",0.75
"chronic kidney disease, stage i or ii",0.75
"other conditions or status of the mother complicating pregnancy, childbirth, or the puerperium",0.2
"diseases of nail, nos",0.05
symptoms of the muscles,0.2
edema,0.3
hydralazine,0.0
insulin soluble,0.75
diabetes insipidus,0.0
anemia of chronic disease,0.2
other hypertensive complications,0.2
"peripheral vascular disease, unspecified",0.25
noninfectious disorders of lymphatic channels,0.0
circulatory disease nec,0.2
disorders of function of stomach,0.1
gastroparesis,0.75
renal dialysis,0.75
chronic ulcer of unspecified site,0.25
chromosomal anomalies,0.1
complication due to other implant and internal device,0.1
effects radiation nos,0.0
pancreatic cancer,0.1
secondary diabetes mellitus,0.0
type 1 diabetes with ketoacidosis,1.0
type 1 diabetes with neurological manifestations,1.0
type 2 diabetes with renal manifestations,0.0
type 2 diabetes with ophthalmic manifestations,0.0
impaired fasting glucose,0.5
hyperparathyroidism,0.1
anemia in chronic kidney disease,0.25
spinocerebellar disease,0.0
peripheral autonomic neuropathy,0.75
other demyelinating diseases of central nervous system,0.1
macular degeneration (senile) of retina nos,0.2
diplopia and disorders of binocular vision,0.1
disorders of vitreous body,0.2
hypertensive chronic kidney disease,0.25
celiac disease,0.5
nephrotic syndrome without mention of glomerulonephritis,0.6
renal failure nos,0.6
disorders resulting from impaired renal function,0.75
secondary hyperparathyroidism (of renal origin),0.2
known or suspected fetal abnormality affecting management of mother,0.0
"cellulitis and abscess of foot, toe",0.35
sarcoidosis,0.0
chronic ulcer of leg or foot,0.7
liraglutide,0.75
glucagon,0.75
"maltase, tissue (group:maltase-tiss)",0.1
type 1 diabetes with renal manifestations,1.0
diabetic retinopathy,0.9
retinal vascular changes and abnomalities,0.75
"chorioretinal inflammations, scars, and other disorders of choroid",0.25
peripheral angiopathy in diseases classified elsewhere,0.75
diabetes or abnormal glucose tolerance complicating pregnancy,0.75
perinatal disorders of digestive system,0.05
corns and callosities,0.2
arthropathy associated with other disorders classified elsewhere,0.2
arthropathy associated with neurological disorders,0.2
open wound of toe(s),0.2
insulins and antidiabetic agents causing adverse effects in therapeutic use,0.75
olmesartan,0.0
glyburide,0.2
exenatide,0.0
graft-versus-host disease,0.0
cancer of eye,0.0
type 1 diabetes with ophthalmic manifestations,1.0
diabetes type 1 with peripheral circulatory disorders,1.0
diabetes type 2 with peripheral circulatory disorders,0.0
polyneuropathy in diabetes,1.0
retinal detachments and defects,0.7
drusen (degenerative) of retina,0.1
hereditary retinal dystrophies,0.1
retinal edema,0.75
disorders of iris and ciliary body,0.1
"renal sclerosis, nos",0.25
renal osteodystrophy,0.25
conditions involving the integument and temperature regulation of fetus and newborn,0.0
nontraumatic compartment syndrome,0.1
gangrene,0.75
complication of amputation stump,0.5
empagliflozin,0.75
dulaglutide,0.75
glimepiride,0.25
repaglinide,0.75
isopropyl alcohol,0.0
saxagliptin,0.75
canagliflozin,0.75
retinal detachment with retinal defect,0.35
congenital anomalies of the eye,0.05
congenital anomalies of posterior segment of eye,0.05
acute graft-versus-host disease,0.0
nonsenile cataract,0.35
invert sugar,0.0
chlorpropamide,0.75
choroidal degenerations,0.1
hiv 1 ab,0.0
urine glucose qualitative,0.75
family history,0.5
lancet,0.5
"inserter,minimed",0.75
"reservoir,minimed",0.75
hemoglobin a1c,0.75
c-peptide,0.75
fasting glucose,0.75
urine glucose test,0.75
accu-chek blood glucose test,0.75
urinary glucose,0.75
glucerna,0.0
infusion set,0.75
needle,0.1
mean blood glucose concentration,0.75
alpha-1 globulin electrophoresis,0.1
capillary blood glucose,0.75
glucose test,0.75
glucose control,0.75
needle/syringe,0.75
"cartridge,animas",0.75
calculated average glucose,0.75
"estimated average glucose, blood",0.75
glucose sensor,0.75
glutamic acid decarboxylase antibody,0.9
insulin antibody,0.75
laboratory reference glucose test,0.75
glucose/ketone test,0.75
calculated mean glucose,0.75
"reservoir,t slim",0.75
alogliptin,0.75
ketone test,0.75
ranibizumab,0.75
diabetisource,0.0
glucose peripheral blood,0.75
glucose intracellular,0.2
serum glucose,0.75
tolazamide,0.75
diurnal urine glucose,0.75
glucose corrected index,0.75
tolbutamide,0.75
estimated mean blood glucose,0.75
date 1,0.0
basal (resting) blood glucose level,0.75
beta hydroxybutyrate comment,0.75
beta hydroxybutyrate (millimoles per liter),0.75
beta hydroxybutyrate - point of care,0.75
glucose tolerance reference range,0.7
"glucose, jackson-pratt drainage",0.2
"glucose, whole blood immediate testing analysis test",0.75
human leukocyte antigen blood draw 1 red,0.5
"human leukocyte antigen luminex class two antibody complement component 1, q subcomponent binding assay donor specific antibody",0.1
insulin coverage glucose,0.85
"insulin, pediatric",0.85
isolate 1,0.0
methaqualone,0.0
procalcitonin study day 1,0.1
total urea (per time period),0.2
total urea nitrogen (per time period),0.25
orotate,0.0
diabetes status,0.75
glimepride,0.75
iddm patient ql,1.0
insulin free,0.75
creatinine,0.5
"insulin isophane / insulin, regular, human",0.75
dapagliflozin,0.75
insulin isophane,0.75
insulin degludec,0.75
glucose / potassium chloride,0.2
"insulin isophane, human",0.75
"insulin, regular, human",0.9
insulin glargine,0.75
"insulin isophane, beef",0.75
"insulin aspart protamine, human",0.75
"insulin glulisine, human",0.75
"insulin aspart, human",0.75
chromium picolinate,0.2
insulin lispro,0.75
dorzolamide,0.0
yellow hornet (dolichovespula arenaria) ige,0.0
peanut (arachis hypogaea) native (nara h) 3 ige,0.0
ethyl glucuronide,0.0
congenital anomalies of intestine,0.05
cholesterol,0.2
clotting time,0.1
trametinib,0.0
ceruloplasmin,0.0
igg clearance/albumin clearance,0.2
salmon (salmo salar) ige,0.0
platelets,0.0
frequency of urination and polyuria,0.75
gardnerella vaginalis dna,0.0
tissue transglutaminase igg,0.75
procedures on the urethra,0.1
other therapeutic endocrine procedures,0.5
astigmatism,0.0
alpha hydroxyalprazolam,0.0
indinavir,0.0
arsenic,0.0
voltage-gated calcium channel p/q type binding ab,0.1
alprazolam,0.0
late effects of cerebrovascular disease,0.1
dementia with cerebral degenerations,0.1
other physical therapy and rehabilitation,0.2
anastrozole,0.0
coxiella burnetii phase 2 igg,0.0
hydroxyproline,0.1
beta 1 globulin,0.0
norepinephrine,0.0
hfe gene mutations tested for,0.1
abnormal tumor markers,0.1
citrulline/creatinine,0.1
ovalbumin ige,0.0
eszopiclone,0.0
chlamydia trachomatis igg,0.0
"gastrectomy, partial and total",0.1
follitropin,0.0
congenital coagulation defects,0.0
leukocytes,0.1
n-methylhistamine/creatinine,0.0
erythematosquamous dermatosis,0.1
base deficit,0.2
"inflammatory disease of cervix, vagina, and vulva",0.0
fine granular casts,0.2
lorazepam,0.0
oral aphthae,0.1
brucella sp igm,0.0
leukocyte phosphatase,0.0
glomerular filtration rate.predicted among blacks,0.2
glutamate decarboxylase 65 ab,0.9
other cns infection and poliomyelitis,0.0
desoximetasone,0.0
throat pain,0.05
painful respiration,0.1
clindamycin,0.0
carbon dioxide (poc) (group:co2-poc),0.1
mononuclear cells,0.1
"creatinine, time ur (mg/dl) (group:tu-cre)",0.2
hemoglobin o-arab/hemoglobin.total,0.0
simeprevir,0.0
human papilloma virus 16+18+31+33+35+45+51+52+56 dna,0.0
norbuprenorphine-glucuronide (group:norbup-gluc),0.0
brazil nut (bertholletia excelsa) ige,0.0
"tco2, cap, nicu (group:tco2cn)",0.0
alpha 1 antitrypsin,0.0
gas delivery source,0.0
drvvt,0.0
cyclosporine,0.1
cladosporium herbarum ige,0.0
open wounds of extremities,0.2
adenovirus ab,0.0
glucose-6-phosphate dehydrogenase,0.1
coarse granular casts,0.2
other diagnostic procedures on lung and bronchus,0.05
cardiac and circulatory congenital anomalies,0.1
"protein, timed urine (mg/tv) (group:utpmgtv)",0.5
specimen volume,0.0
"docusate / sennosides, usp",0.0
chlamydophila pneumoniae ab,0.0
guaifenesin / pseudoephedrine,0.0
infectious and parasitic complications affecting pregnancy,0.1
coagulation factor x activity actual/normal,0.1
stress fracture,0.1
alcoholic liver damage,0.0
hepatitis d virus ab,0.0
hct (bg) (group:hct bg),0.2
nausea and vomiting,0.2
creatinine dialysis fluid clearance,0.2
fat emulsion,0.0
penicillium notatum ige,0.0
primidone,0.0
fiber,0.0
deprecated c trach rrna xxx ql prb,0.0
sjogrens syndrome-b extractable nuclear ab,0.1
cocksfoot (dactylis glomerata) ige,0.0
deprecated mean glucose bld ghb est-acnc,0.75
disorders of the globe,0.0
corneal opacity and other disorders of cornea,0.2
blindness and low vision,0.6
disorders of lacrimal system,0.05
disorders of optic nerve and visual pathways,0.2
other disorders of eye,0.2
nephritis and nephropathy with pathological lesion,0.75
disorders of conjunctiva,0.1
other disorders of eyelids,0.1
chorioretinal scars,0.2
"uveitis, noninfectious or nos",0.2
benign neoplasm of eye,0.0
cystoid macular degeneration of retina,0.5
retinal hemorrhage/ischemia,0.75
minoxidil,0.0
cobalamin,0.1
"bandage,gauze",0.1
beta-hydroxybutyrate,0.75
microalbumin spot,0.75
microalbumin/creatinine ratio,0.75
acetone titer,0.75
glycosylated hemoglobin,0.75
streck sedimentation rate,0.2
benzodiazepines,0.0
barbiturates,0.0
benzoylecgonine,0.0
methadone,0.0
phencyclidine,0.0
cannabinoids,0.0
opiates,0.0
ascorbic acid / folic acid / iron carbonyl / vitamin b12,0.1
glucose / sodium chloride,0.2
"insulin lispro protamine, human",0.9
hydroxocobalamin,0.1
cyanocobalamin.unsaturated binding capacity,0.1
optic neuritis/neuropathy,0.2
kidney replaced by transpant,0.25
open wound or laceration of eye or eyelid,0.05
other disorders of lipoid metabolism,0.2
strabismus (not specified as paralytic),0.05
peripheral vascular disease,0.5
cellulitis and abscess of fingers/toes,0.2
hemoglobin a1c/hemoglobin.total,0.75
acute osteomyelitis,0.25
amputation of lower extremity,0.6
"keratoderma, acquired",0.1
calcium acetate,0.1
osteomyelitis,0.25
"osteomyelitis, periostitis, and other infections involving bone",0.25
nephritis; nephrosis; renal sclerosis,0.75
renal failure,0.7
open wound of foot except toe(s) alone,0.2
atherosclerosis of the extremities,0.6
paricalcitol,0.1
ingrowing nail,0.0
unspecified osteomyelitis,0.2
hypercholesterolemia,0.25
atherosclerosis of native arteries of the extremities with ulceration or gangrene,0.75
keratoconus,0.1
corneal opacity,0.2
myopia,0.0
corneal dystrophy,0.1
corneal degenerations,0.2
separation of retinal layers,0.7
disorders of refraction and accommodation; blindness and low vision,0.2
peripheral retinal degenerations,0.7
disorders of the orbit,0.0
exophthalmos,0.1
mixed hyperlipidemia,0.3
dry eyes,0.2
optic atrophy,0.2
igg subclass 1,0.1
"glucose, pericardial fluid",0.2
"1,3 beta glucan",0.0
estimated average glucose,0.75
glucose oxidase,0.5
molecular class one typing,0.1
yeast,0.0
lot number capillary glucose,0.75
point of care urine glucose,0.75
iga subclass 1,0.1
nidus,0.0
cellulose,0.0
fingerstick glucose,0.75
aldolase,0.0
hiv genotype,0.0
direct immunofluorescence,0.1
dimethyl fumarate,0.0
diagnosis code,0.0
amylase,0.1
urinary glucose concentration,0.75
rate,0.0
acetohexamide,0.75
insulin detemir,0.75
adenovirus,0.0
date contacted,0.0
dextrose/sodium chloride,0.2
glucose tolerance 50 gram screen,0.5
cushing's syndrome,0.1
"glucose, capillary blood. device comment.",0.75
daily mean blood glucose concentration,0.75
dysthymic disorder,0.0
alpha 1 antitrypsin phenotype,0.0
iatrogenic endocrine disorders,0.5
immunoelectrophoresis: alpha 1 globulin,0.1
primary open angle glaucoma,0.2
occult blood test day 1,0.1
alpha-1-antitrypsin deficiency,0.1
calculated average plasma glucose,0.75
quick parathyroid hormone number 1,0.1
streptozocin,0.75
primary angle-closure glaucoma,0.1
chronic ulcer of skin,0.3
presbyopia,0.0
chronic osteomyelitis,0.2
other forms of chronic heart disease,0.25
traumatic amputation,0.2
senile cataract,0.5
"lactase, tissue (group:lactase-tiss)",0.0
hyperlipidemia,0.25
disorders of lipoid metabolism,0.25
aflibercept,0.0
glyburide / metformin,0.75
telmisartan,0.25
glycosuria or acetonuria,0.75
perindopril,0.0
valsartan,0.0
benazepril,0.25
disorders of calcium/phosphorus metabolism,0.2
sodium ferric gluconate complex,0.0
becaplermin,0.0
moexipril,0.0
cinacalcet,0.0
doxercalciferol,0.0
hypothyroidism nos,0.1
flutamide,0.0
disorders of phosphorus metabolism,0.2
other endocrine disorders,0.5
other disorders of carbohydrate transport and metabolism,0.7
preeclampsia and eclampsia,0.2
"hypertension complicating pregnancy, childbirth, and the puerperium",0.0
congenital anomalies of face and neck,0.0
disorders of the autonomic nervous system,0.25
acute renal failure,0.5
hyperosmolality and/or hypernatremia,0.5
disorders of porphyrin metabolism,0.1
severe protein-calorie malnutrition,0.2
cystic kidney disease,0.1
fluid overload,0.2
urine glucose concentration,0.75
dme and supplies,0.5
oligosaccharides,0.0
ketones,0.75
alpha 1 globulin,0.1
time 1,0.0
igd,0.0
eating disorder,0.1
device,0.0
alpha ketoglutarate,0.1
sucrose,0.0
hiv 1 rna,0.0
cell type,0.0
acid alpha glucosidase,0.1
dornase alfa,0.0
herpes simplex virus 1 immunoglobulin m titer,0.0
glycated hemoglobin a1c,0.75
anemia during pregnancy,0.1
occult blood day 1 screening test,0.1
diseases of pancreas,0.75
congenital hypothyroidism,0.1
takayasu's disease,0.0
breast cancer [male],0.0
polyglandular activity in multiple endocrine adenomatosis,0.25
"thyroiditis, acute and subacute",0.1
estimated average glucose (eag),0.75
blister,0.1
"creation, revision and removal of arteriovenous fistula or vessel-to-vessel cannula for dialysis",0.2
osteitis deformans and osteopathies associated with other disorders classified elsewhere,0.1
sevelamer carbonate,0.0
iron sucrose,0.1
pramlintide,0.75
capsaicin,0.0
candesartan cilexetil,0.5
epoetin alfa,0.1
"insulin lispro / insulin lispro protamine, human",0.75
lovastatin,0.2
transferrin,0.1
glipizide,0.75
gemfibrozil,0.25
atherosclerosis,0.5
colesevelam,0.75
quinapril,0.0
sodium polystyrene sulfonate,0.0
pioglitazone,0.75
fosinopril,0.5
trandolapril,0.0
erectile dysfunction [ed],0.5
coma,0.5
other disorders of arteries and arterioles,0.5
spironolactone,0.1
"albumin human, usp",0.2
secondary/extrinsic cardiomyopathies,0.2
primary/intrinsic cardiomyopathies,0.2
abnormal function study of cardiovascular system,0.25
disorders of parathyroid gland,0.1
other disorders of the kidney and ureters,0.25
lipoprotein disorders,0.25
niacin,0.0
"overweight, obesity and other hyperalimentation",0.25
enalaprilat,0.0
gouty arthropathy,0.1
amyloidosis,0.1
lack of coordination,0.2
congestive heart failure (chf) nos,0.25
myoneural disorders,0.0
cardiomegaly,0.25
dysmetabolic syndrome x,0.5
other hypertrophic cardiomyopathy,0.1
unspecified disorder of lipoid metabolism,0.2
acidosis,0.75
disorders of magnesium metabolism,0.1
disorders of mineral metabolism,0.2
hirsutism,0.1
other abnormal blood chemistry,0.5
nonspecific findings on examination of blood,0.2
endocrine and metabolic disturbances of fetus and newborn,0.2
blood vessel replaced,0.2
intestinal disaccharidase deficiencies and disaccharide malabsorption,0.1
other disorders of purine and pyrimidine metabolism,0.1
hypercalcemia,0.1
glucocorticoid deficiency,0.2
disorders of iron metabolism,0.1
electrolyte imbalance,0.5
hepatomegaly,0.2
abnormal serum enzyme levels,0.25
hyperaldosteronism,0.1
hypertensive heart disease,0.2
proliferative glomerulonephritis,0.5
"congenital anomaly of gallbladder, bile ducts, liver, pancreas",0.1
disorders of other cranial nerves,0.1
inflammatory and toxic neuropathy,0.25
other specified congenital anomalies of kidney,0.1
nerve plexus lesions,0.25
carnitine deficiencies,0.1
"complication of nervous system device, implant, and graft",0.1
paralytic strabismus,0.1
other and unspecified disorders of the nervous system,0.1
intestinal malabsorption (non-celiac),0.1
musculoskeletal symptoms referable to limbs,0.1
sensorineural hearing loss,0.1
other perinatal conditions of fetus or newborn,0.1
other and unspecified congenital anomalies,0.1
myopathy,0.2
degenerative disease of the spinal cord,0.0
pituitary hypofunction,0.1
unspecified diffuse connective tissue disease,0.1
spinal cord injury without evidence of spinal bone injury,0.0
chronic venous insufficiency [cvi],0.1
"hemangioma and lymphangioma, any site",0.0
panniculitis,0.1
disease of capillaries,0.3
splenomegaly,0.1
disorders of bilirubin excretion,0.1
disorders of amino-acid metabolism,0.1
gout,0.1
"neuralgia, neuritis, and radiculitis nos",0.1
disturbances of amino-acid transport,0.1
myasthenia gravis,0.0
hypoparathyroidism,0.1
congenital cataract and lens anomalies,0.2
other deficiencies of circulating enzymes,0.2
complications of surgical and medical procedures,0.2
progressive myopia,0.0
other tests,0.1
"benign neoplasm of eye, uveal",0.1
rickets or osteomalacia,0.1
muscular dystrophies,0.0
disorders involving the immune mechanism,0.75
"effects of heat, cold and air pressure",0.1
symptoms and disorders of the joints,0.1
complex regional/central pain syndrome,0.1
retinoschisis and retinal cysts,0.25
macular puckering of retina,0.5
somatotropin,0.1
starch,0.0
chlorambucil,0.0
albumin,0.5
albumin/creatinine,0.75
ethinyl estradiol / ethynodiol,0.0
cadexomer iodine,0.0
dactinomycin,0.0
sevelamer hydrochloride,0.1
chronic lymphocytic thyroiditis,0.2
ophthalmologic and otologic diagnosis and treatment,0.3
althete's foot,0.1
supply,0.0
"repair of retinal tear, detachment",0.25
other hypertrophic and atrophic conditions of skin,0.1
"other diagnostic procedures (interview, evaluation, consultation)",0.1
"bandage,gauze elastic",0.1
"superficial injury, infected",0.1
urine microalbumin concentration,0.75
other peripheral nerve disorders,0.1
rosiglitazone,0.75
yohimbine,0.0
mannitol,0.1
urea,0.2
human leukocyte antigen luminex class one antibody complement component 1q binding assay donor specific antibody,0.1
enalapril,0.25
corrected calcium,0.2
acetoacetate,0.75
human leukocyte antigen lactate dehydrogenase preliminary workup report,0.2
viral pneumonia,0.1
dysplasia of cervix,0.0
"insulin aspart protamine, human / insulin aspart, human",0.9
amphetamine,0.0
heart transplant/surgery,0.1
sirolimus,0.1
other cholesterol,0.25
potassium chloride / sodium chloride,0.1
call back log at,0.0
who received phone results at,0.0
lung transplant,0.1
amphotericin b lipid complex,0.0
other nutritional deficiency,0.2
immunity deficiency,0.1
hyperchylomicronemia,0.1
procedure,0.0
drugs identified,0.0
sickle cell anemia,0.0
abnormality of red blood cells,0.2
corticotropin,0.1
calcitriol,0.1
peginterferon alfa-2b,0.0
charcoal,0.0
interferon gamma-1b,0.1
cortisone,0.2
cisapride,0.0
deficiency anemias,0.1
secondary thrombocytopenia,0.1
pneumonia due to fungus (mycoses),0.2
myocarditis,0.2
"complications of cardiac/vascular device, implant, and graft",0.25
clopidogrel,0.1
hepatitis b virus surface ab,0.0
"medications (injections, infusions and other forms)",0.75
carvedilol,0.2
protein/creatinine,0.5
gerd,0.1
hypothyroidism,0.2
labetalol,0.25
coronary atherosclerosis,0.25
"iron deficiency anemias, unspecified or not due to blood loss",0.1
phentolamine,0.1
nicotinamide,0.5
erythropoietin,0.1
malaise and fatigue,0.5
ezetimibe,0.0
occlusion and stenosis of precerebral arteries,0.25
cyclophosphamide,0.1
ischemic heart disease,0.25
"endarterectomy, vessel of head and neck",0.1
oxygen,0.0
other intraocular therapeutic procedures,0.1
persistent vomiting,0.3
fenofibrate,0.2
niacinamide,0.0
fenoldopam,0.0
disorders of adrenal glands,0.1
testicular hypofunction,0.1
varicose veins,0.0
hereditary and idiopathic peripheral neuropathy,0.5
vitamin b-complex deficiencies,0.1
injuries to the nervous system,0.1
"other conditions of brain, nos",0.1
mental retardation,0.0
congenital anomalies of skin,0.0
acute pain,0.1
other infectious and parasitic diseases,0.1
precocious sexual development and puberty nec,0.0
adrenogenital disorders,0.1
abnormal findings on examination of urine,0.5
other disorders of male genital organs,0.0
other cerebral degenerations,0.0
obstetrical/birth trauma,0.0
develomental delays and disorders,0.1
sexually transmitted infections (not hiv or hepatitis),0.0
other disorders of soft tissues,0.0
bariatric surgery,0.25
disorders of copper metabolism,0.0
abnormality of secretion of glucagon or gastrin,0.7
hypocalcemia,0.2
superficial cellulitis and abscess,0.25
sodium hypochlorite,0.0
adverse reaction to serum or vaccine,0.1
behcet's syndrome,0.0
congenital anomalies of the integument,0.0
other paralytic syndromes,0.1
other specified congenital anomalies of nervous system,0.0
"anomalies of endocrine glands, congenital",0.2
disorder of skin and subcutaneous tissue nos,0.1
vitamin a deficiency,0.1
mineral deficiency nec,0.2
acquired hypothyroidism,0.1
lipoma of skin and subcutaneous tissue,0.0
vitiligo,0.2
mycoses,0.1
congenital osteodystrophies,0.1
congenital anomalies of genital organs,0.0
"persons with potential health hazards related to socioeconomic, psychosocial, and other circumstances",0.2
"hiv infection, symptomatic",0.0
neoplasm of uncertain behavior,0.1
other disorders of thyroid,0.1
coccidioidomycosis,0.0
other hemoglobinopathies,0.0
hereditary hemochromatosis,0.1
other vitamin b12 deficiency anemia,0.1
hypopotassemia,0.2
other complications of the puerperium nec,0.1
disorders of the pituitary gland and its hypothalamic control,0.2
"varicose veins of lower extremity, symptomtic",0.0
other local infections of skin and subcutaneous tissue,0.2
complications of transplants and reattached limbs,0.1
deficiency of humoral immunity,0.2
vascular disorders of kidney/hypertrophy,0.25
infections specific to the perinatal period,0.1
non-proliferative glomerulonephritis,0.5
anomalies of tooth position/malocclusion,0.1
candidiasis,0.2
nutritional marasmus,0.1
traumatic cataract,0.2
raynaud's syndrome,0.1
vitamin c deficiencies,0.1
foreign body injury,0.0
crushing or internal injury to organs,0.0
superficial injury without mention of infection,0.0
polyphagia,0.75
"esophagitis, gerd and related diseases",0.1
functional digestive disorders,0.1
hypochlorite,0.0
chronic thyroiditis,0.2
"chronic glomerulonephritis, nos",0.5
gliadin antibodies,0.2
sodium ascorbate,0.1
cyanide,0.0
saint michael's hospital blood bank test,0.1
urea nitrogen,0.2
calcium,0.1
human leukocyte antigen lactate dehydrogenase final workup report,0.2
diseases of white blood cells,0.1
other disorders of bone and cartilage,0.1
arthropod-borne diseases,0.0
congenital anomalies of peripheral vascular system,0.1
digestive congenital anomalies,0.0
burns,0.0
diseases of esophagus,0.1
decubitus ulcer,0.2
chronic venous hypertension,0.1
"cellulitis and abscess of leg, except foot",0.2
collagenase,0.0
chlorthalidone,0.2
aseptic necrosis of bone,0.2
alcohol-related disorders,0.1
cystic fibrosis,0.1
localized adiposity,0.2
swelling of limb,0.2
ethosuximide,0.0
"laminectomy, excision intervertebral disc",0.0
microscopic observation,0.1
computerized axial tomography (ct) scan head,0.1
lamotrigine,0.0
dihydrocodeine,0.0
"traction, splints, and other wound care",0.1
oxycodone,0.0
appearance,0.0
other diagnostic procedures on skin and subcutaneous tissue,0.1
"other therapeutic procedures on eyelids, conjunctiva, cornea",0.1
epinephrine,0.1
protein,0.0
amitriptyline,0.1
topiramate,0.0
lithium,0.0
lactate,0.2
virus identified,0.1
incision and excision of cns,0.0
other non-epithelial cancer of skin,0.0
melanomas of skin,0.0
prophylactic vaccinations and inoculations,0.1
dermatomycoses,0.1
gabapentin,0.0
meperidine,0.0
magnetic resonance imaging,0.1
clostridioides difficile toxin a+b,0.0
amphetamines,0.0
hydromorphone,0.0
clobazam,0.0
parathyrin.intact,0.0
cortisol,0.2
acetaminophen,0.0
"hip replacement, total and partial",0.1
abnormal weight gain,0.2
diagnostic ultrasound of urinary tract,0.1
vitamin d deficiency,0.2
gastric bypass and volume reduction,0.2
qualitative platelet defects,0.1
cancer of other female genital organs,0.0
malignant neoplasm of ovary,0.0
"malignant neoplasm, other",0.0
biopsy of liver,0.1
non-hodgkins lymphoma,0.0
intestinal infection,0.1
bacterial enteritis,0.1
deprecated heparin plas-mcnc,0.0
herpes zoster,0.1
infliximab,0.0
lactoferrin,0.0
"upper gastrointestinal endoscopy, biopsy",0.2
cold agglutinin,0.0
mycophenolate,0.0
buprenorphine,0.0
tryptophan,0.0
abortion (termination of pregnancy),0.0
delirium dementia and amnestic and other cognitive disorders,0.1
lidocaine,0.0
codeine,0.0
dexamethasone,0.1
tacrolimus,0.1
sexual and gender identity disorders,0.0
lymphadenitis,0.1
"congenital anomalies of upper limb, including shoulder girdle",0.0
hyperemesis gravidarum,0.0
viral infection,0.1
torsion dystonia,0.0
psychosis,0.1
other immunological findings,0.2
other hernia repair,0.0
7-aminoclonazepam,0.0
vitamin deficiency,0.2
bacterial infection nos,0.0
valproate,0.0
anxiety disorder,0.1
depression,0.25
purpura and other hemorrhagic conditions,0.1
neurological disorders,0.2
lutropin,0.0
partial excision bone,0.1
diagnostic ultrasound of head and neck,0.1
sodium,0.2
scleritis and episcleritis,0.1
otitis externa,0.1
"conjunctivitis, infectious",0.1
otalgia,0.0
other headache syndromes,0.1
migraine,0.0
tetrahydrocannabinol,0.0
generalized convulsive epilepsy,0.1
extrapyramidal disease and abnormal movement disorders,0.0
dizziness and giddiness (light-headedness and vertigo),0.2
methylenedioxymethamphetamine,0.0
other mental disorder,0.1
substance addiction and disorders,0.1
carbamazepine,0.0
hearing loss,0.1
benign neoplasm of unspecified sites,0.0
other benign neoplasm of connective and other soft tissue,0.0
methylmalonate,0.0
clonazepam,0.0
benign neoplasm of other parts of digestive system,0.1
lipoma,0.0
cachexia,0.25
congenital anomaly of fingers/toes,0.0
anorexia,0.1
congenital anomalies of skull and face bones,0.0
"cerebral degeneration, unspecified",0.1
diseases of thymus gland,0.1
glossitis,0.1
rhabdomyolysis,0.1
congenital anomalies of abdominal wall; diaphram,0.0
excessive vomiting in pregnancy,0.1
pallor and flushing,0.1
neural tube defects,0.1
other upper respiratory disease,0.0
other disorders of ear,0.0
paralysis/spasm of vocal cords or larynx,0.05
symptoms involving respiratory system and other chest symptoms,0.2
streptococcus infection,0.1
nervous system congenital anomalies,0.1
acute pharyngitis,0.0
fracture of unspecified part of femur,0.1
disturbances of sensation of smell and taste,0.1
effects of other external causes,0.0
congenital anomalies of stomach,0.0
dexpanthenol,0.0
calcifediol,0.1
sleep disorders,0.2
midodrine,0.0
amphetamines quantitative test,0.1
skull and face fracture and other intercranial injury,0.0
hemorrhage nos,0.1
hemorrhage of fetus or newborn,0.1
rheumatoid arthritis,0.0
dysphagia,0.1
diseases of the larynx and vocal cords,0.0
other specified peripheral vascular diseases,0.2
"encephalopathy, not elsewhere classified",0.1
urticaria,0.1
"injury, nos",0.0
symptoms involving cardiovascular system,0.25
other disorders of liver,0.1
hypotension nos,0.1
pervasive developmental disorders,0.0
diseases of lips,0.0
nerve root and plexus disorders,0.2
pulmonary heart disease,0.1
symptoms involving digestive system,0.25
arteritis nos,0.1
protein-calorie malnutrition,0.2
other disorders of intestine,0.1
chronic pulmonary heart disease,0.1
arterial dissection,0.1
carcinoid syndrome,0.1
"other diseases of respiratory system, not elsewhere classified",0.0
respiratory arrest,0.1
hypoventilation,0.1
respiratory abnormalities,0.1
nonrheumatic pulmonary valve disorders,0.0
cardiac shunt/ heart septal defect,0.1
other ill-defined and unknown causes of morbidity and mortality,0.1
cardiac congenital anomalies,0.1
congenital anomalies of great vessels,0.0
cerebral cysts,0.1
respiratory conditions of fetus and newborn,0.0
myoclonus,0.1
apnea,0.1
valvular heart disease/ heart chambers,0.1
other alveolar and parietoalveolar pneumonopathy,0.0
other hereditary hemolytic anemias,0.0
voice disturbance,0.1
personal history of diseases of blood and blood-forming organs,0.0
maternal complication of pregnancy affecting fetus or newborn,0.2
tics and choreas,0.0
cilostazol,0.0
arterial embolism and thrombosis,0.2
"swelling, mass, or lump in head and neck [space-occupying lesion, intracranial nos]",0.1
disturbance of skin sensation,0.2
congenital anomalies of limbs,0.0
morbid obesity,0.2
orlistat,0.25
ichthyosis congenita,0.0
sleep apnea,0.2
congenital deformities of feet,0.0
acquired absence of breast,0.0
other acquired musculoskeletal deformity,0.1
disorders of urea cycle metabolism,0.1
tuberculosis,0.0
diseases of spleen,0.1
alkalosis,0.1
helminthiases,0.0
other diseases of blood and blood-forming organs,0.1
endocarditis,0.1
clonidine,0.1
"polycythemia vera, secondary",0.0
pneumonia,0.2
sepsis,0.2
brimonidine / timolol,0.0
thrombocytopenia,0.1
lyme disease,0.0
acute pericarditis,0.1
visual disturbances,0.3
other disorders of circulatory system,0.2
infection/inflammation of internal prosthetic device; implant; and graft,0.1
visual field defects,0.25
arterial embolism and thrombosis of lower extremity artery,0.25
staphylococcus infections,0.2
postoperative infection,0.2
"viremia, nos",0.0
infective connective tissue disorders,0.0
bronchopneumonia and lung abscess,0.1
pentoxifylline,0.0
atheroembolism,0.2
sideroblastic anemia,0.0
acid-base balance disorder,0.3
paraproteinemia,0.1
toxic effect of lead and its compounds (including fumes),0.0
ertapenem,0.0
silver sulfadiazine,0.0
"respiratory failure, insufficiency, arrest",0.1
systemic sclerosis,0.0
skin graft,0.1
abnormal involuntary movements,0.2
adverse drug events and drug allergies,0.2
hypovolemia,0.1
alcoholism,0.1
heparin,0.0
"heparin, porcine",0.1
pancreatin,0.2
hereditary disturbances in tooth structure,0.0
sicca syndrome,0.1
other specified disorders involving the immune mechanism,0.2
hepatitis nos,0.0
alopecia,0.1
psychogenic disorder,0.1
"diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue",0.1
somatoform disorder,0.0
other dyschromia,0.1
complication of internal orthopedic device,0.1
other derangement of joint,0.1
late effect,0.0
symptoms affecting skin,0.25
diagnostic physical therapy,0.2
kyphoscoliosis and scoliosis,0.0
degenerative and vascular disorders of ear,0.0
other congenital musculoskeletal anomalies,0.0
ofloxacin,0.0
infantile cerebral palsy,0.0
canagliflozin / metformin,0.75
dapagliflozin / metformin,0.75
disorders of carbohydrate transport and metabolism,0.75
aortic aneurysm,0.1
sodium bicarbonate,0.1
"acute glomerulonephritis, nos",0.5
conductive hearing loss,0.1
facial nerve disorders [cn7],0.1
fructose,0.0
disorders of acoustic nerve,0.0
tympanosclerosis and middle ear disease related to otitis media,0.0
cervical radiculitis,0.0
other disorders of tympanic membrane,0.0
otorrhea,0.0
cholesteatoma,0.0
other disorders of middle ear and mastoid,0.0
otitis media,0.1
meniere's disease,0.0
azathioprine,0.1
crushing injury,0.0
hemoglobin s,0.0
other chronic nonalcoholic liver disease,0.1
hyaluronate,0.0
non-healing surgical wound,0.35
embolectomy and endarterectomy of lower limbs,0.2
diazoxide,0.75
gauze pad,0.1
zinc transporter 8 ab,0.9
ancillary services,0.1
adjustment reaction,0.0
insulin isophane-insulin regular,0.75
thyroiditis,0.2
impulse control disorder,0.0
potassium acetate,0.1
cholesterol in hdl,0.25
conduct disorders,0.0
cholesterol in ldl,0.25
abnormal posture,0.1
iga,0.0
insulin lispro protamine- and insulin lispro-containing product,0.9
human papillomavirus vaccine,0.0
cholesterol in vldl,0.3
thyroxine,0.1
"influenza virus vaccine, inactivated",0.1
eosinophilic esophagitis,0.1
thyrotropin,0.1
metformin,0.75
thyroxine free,0.1
serology studies,0.2
psychological and psychiatric evaluation and therapy,0.2
thyroxine/triiodothyronine uptake index,0.1
mood disorders,0.2
noninfectious gastroenteritis,0.1
generalized anxiety disorder,0.1
irregular menstrual cycle/bleeding,0.2
cocaine,0.0
meningococcal conjugate vaccine,0.0
toxicology studies,0.1
potassium phosphate,0.2
symptoms involving nervous and musculoskeletal systems,0.3
ubidecarenone,0.0
meningitis,0.0
other complications of pregnancy nec,0.1
fever of unknown origin,0.1
lmw heparin,0.2
leukocyte esterase,0.1
bacteria identified,0.1
ascorbic acid / biotin / folic acid / mecobalamin / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine,0.1
hepatitis c virus ab,0.1
hepatitis c virus ab signal/cutoff,0.1
sitagliptin,0.75
fish oils,0.2
creatinine/body weight,0.3
nonspecific abnormal findings in cerebrospinal fluid,0.1
degenerative skin disorders,0.1
olmesartan medoxomil,0.1
insulin glargine / lixisenatide,0.75
"insulin isophane, human 50 unt/ml / insulin, regular, human 50 unt/ml injectable suspension [humulin]",0.9
pancreatic polypeptide,0.2
glycated hemoglobin a1c as a percentage of total hemoglobin,0.75
insulin degludec / liraglutide,0.75
creatinine microalbumin ratio,0.75
creatinine and urine albumin measurements in urine sample,0.75
"insulin, regular, human 100 unt/ml injectable solution [velosulin]",0.9
microalbumin to creatinine ratio,0.75
"3 ml insulin, regular, human 100 unt/ml prefilled syringe [novolin r]",0.75
urine albumin-creatinine ratio,0.75
convulsions,0.2
chromosomal anomalies and genetic disorders,0.2
potassium,0.2
altered mental status,0.25
osteopenia or other disorder of bone and cartilage,0.2
other arthropathies,0.1
systemic lupus erythematosus,0.1
heparin unfractionated,0.1
myocardial infarction,0.25
toxic effect of other metals,0.0
dementias,0.1
"congenital anomalies of muscle, tendon, fascia, and connective tissue",0.0
specific nonpsychotic mental disorders due to brain damage,0.0
other symptoms,0.2
burr cells,0.0
reticulocytes/100 erythrocytes,0.1
target cells,0.2
fungus identified,0.0
prednisolone,0.5
erythrocytes,0.1
sickle cells,0.0
spherocytes,0.0
elliptocytes,0.0
tics and stuttering,0.0
cholesterol non hdl,0.3
hemoglobin a1c test - differential cell count type,0.75
angina pectoris,0.25
glycated hemoglobin,0.75
elevated blood pressure reading without diagnosis of hypertension,0.2
mecobalamin,0.0
atherosclerosis of renal artery,0.5
isopropyl alcohol topical product,0.0
peginterferon alfa-2a,0.0
abdominal pain,0.2
atopic/contact dermatitis due to other or unspecified,0.0
tablet,0.0
alanine aminotransferase,0.2
neomycin / polymyxin b / prednisolone,0.0
arrhythmia (cardiac) nos,0.2
interferon alfa-2b,0.1
phlebitis and thrombophlebitis,0.1
delavirdine,0.0
creatine kinase,0.1
diarrhea,0.1
iga.kappa,0.0
"allergies, other",0.0
other symptoms/disorders or the urinary system,0.2
pruritus and related conditions,0.2
rash and other nonspecific skin eruption,0.1
pain,0.2
cough,0.1
erythematous conditions,0.1
hypotension,0.2
tachycardia nos,0.2
ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate,0.0
insulin-like growth factor ii,0.3
protein.monoclonal,0.2
globulin,0.2
polydipsia,0.75
protein fractions,0.2
chloramphenicol,0.0
epinephrine / lidocaine,0.1
alpha linolenate (c18:3w3),0.1
miscarriage; stillbirth,0.1
chronic vascular insufficiency of intestine,0.2
problems associated with amniotic cavity and membranes,0.0
venous/cerebrovascular complications embolism in pregnancy and the puerperium,0.1
toxic effect of carbon monoxide,0.0
femoral hernia,0.0
coenzyme q10,0.1
contusion,0.0
osteoporosis nos,0.2
other and unspecified coagulation defects,0.1
phosphatidylserine ab,0.1
other venous embolism and thrombosis,0.1
infection of the eye,0.2
breast disorder nos,0.0
cancer of other endocrine glands,0.1
"pulmonary embolism and infarction, acute",0.1
fetal distress and abnormal forces of labor,0.0
histoplasmosis,0.0
hemoglobinuria,0.1
aspergillosis,0.0
cardiolipin ab,0.1
hematological disorders of newborn,0.0
cerebrovascular disease,0.25
"cerebral artery occlusion, with cerebral infarction",0.25
wegener's granulomatosis,0.0
ibuprofen,0.0
disturbances of sulphur-bearing amino-acid metabolism,0.1
certain early complications of trauma or procedure,0.0
hemoptysis,0.1
chronic pericarditis,0.1
benign neoplasm of respiratory and intrathoracic organs,0.0
other pulmonary inflamation or edema,0.1
short gestation; low birth weight; and fetal growth retardation,0.2
blood transfusion,0.1
iron saturation,0.1
folate,0.1
cerebral ischemia,0.25
cirrhosis of liver without mention of alcohol,0.2
pulmonary collapse; interstitial and compensatory emphysema,0.0
isoimmunization of fetus or newborn,0.0
cholecalciferol,0.2
carotene,0.0
asphyxia and hypoxemia,0.0
elevated white blood cell count,0.2
pyelonephritis,0.2
pericarditis,0.1
pneumoconiosis,0.0
"infertility, female, associated with anovulation",0.1
intestinal helminthiases,0.0
other diseases of lung,0.1
jaundice (not of newborn),0.1
hypothermia/chills,0.1
lactate dehydrogenase,0.1
pyruvate/creatinine,0.1
chronic pancreatitis,0.3
hypotony of eye,0.1
glucose capillary (point of care),0.75
alglucosidase alfa,0.0
"symptoms concerning nutrition, metabolism, and development",0.6
body weight,0.3
poisoning by hormones and synthetic substitutes,0.1
gingival and periodontal diseases,0.2
glucose arterial (point of care),0.75
lung disease due to external agents,0.0
hyperhidrosis,0.1
kidney transplant,0.5
muscle weakness,0.2
other degenerative diseases of the basal ganglia,0.0
ethacrynic acid,0.0
tofacitinib,0.0
eribulin,0.0
glipizide / metformin,0.75
tolcapone,0.0
cabozantinib,0.0
muromonab-cd3,0.0
orphenadrine,0.0
fingolimod,0.0
crizotinib,0.0
nitroglycerin,0.0
aldesleukin,0.0
alemtuzumab,0.75
retinopathy of prematurity,0.1
ketamine,0.0
polyneuropathy due to drugs,0.25
acquired foot deformities,0.3
ramipril,0.75
adenosine deaminase,0.1
potassium gluconate,0.1
dacrocytes,0.0
talc,0.0
acarbose,0.25
fat,0.1
glucosamine,0.1
adenovirus dna,0.1
crystals,0.05
reducing substances,0.2
sorbitol,0.1
adipate/creatinine,0.1
collection date,0.1
doxycycline,0.05
tropicamide,0.1
weight,0.2
lactic acid,0.25
ascvd,0.3
acecarbromal,0.0
pathology,0.5
personality disorders,0.05
water,0.0
liquefaction,0.0
specimen source,0.1
alprostadil,0.05
1-methylhistidine,0.1
patient symptoms,0.5
hypromellose,0.1
alpha subunit,0.05
ethylene glycol,0.1
adenovirus ag,0.1
cardiac defibrillator in situ,0.1
juvenile rheumatoid arthritis,0.0
breast cancer [female],0.0
deprecated glucose serpl-mcnc,0.75
"gtt, 2 hour (group:2hrgtt)",0.75
thyroid cancer,0.1
rhesus isoimmunization in pregnancy,0.0
"gtt, 3 hour (group:3hrgtt)",0.5
thyroglobulin (tumor) (group:thygtm),0.1
cyst and pseudocyst of pancreas,0.2
dissociative disorder,0.0
breast cancer,0.0
pernicious anemia,0.1
thyrotoxicosis with or without goiter,0.1
chronic graft-versus-host disease,0.05
interpretation (thyroglobulin) (group:thyr-int),0.1
dermatomyositis,0.1
pth (intraoperative) (group:pthintop),0.05
donor type (group:donr-type),0.0
multiple myeloma,0.0
first degree av block,0.1
glomerulonephritis,0.25
cellulose/talc,0.0
drain,0.05
glytrol,0.5
injector,0.5
dressing,0.1
drip collector,0.0
mode,0.0
lotion,0.05
keri,0.0
uni-derm,0.0
specimen type,0.1
blood amylase,0.1
glycolic acid,0.0
resource,0.0
fasting specimen,0.5
"dressing,wet",0.1
nutren,0.0
moisturizer,0.1
urinary glucose - semi-quantitative,0.5
inspirease,0.0
immunoglobulin a,0.2
alpha immunoglobulin count,0.1
honey preparation,0.1
point of care glucose test,0.75
beta-1 globulin concentration,0.1
fecal immunochemical test 1 of 1,0.0
alpha-1 globulin concentration,0.1
alpha-1 globulin fraction,0.1
occult blood fecal immunochemical test screen 1 of 1,0.05
urine glucose semi-quantitative test (pregnancy),0.25
microalbuminuria,0.75
immunochemical fecal occult blood test 1,0.05
chart diagnosis,0.0
donor percent,0.0
aspartame,0.0
phenotype,0.5
direct examination,0.1
medication prescribed,0.5
called results,0.0
maltodextrin,0.1
medications,0.5
urine ketone one hour,0.75
"1,5-anhydroglucitol",0.75
date reported,0.0
source,0.0
class,0.0
direct antiglobulin test blood bank,0.1
insulin-like growth factor 1,0.25
"prothrombin time, 1 to 1 dilution",0.1
alpha-1-antitrypsin phenotype,0.05
genetic disease analysis overall interpretation,0.4
delivery date,0.1
"amylase, jackson-pratt drainage",0.1
lipoprotein fractions,0.25
autoimmune disease nec,0.7
syncope and collapse,0.1
nonspecific chest pain,0.05
hemoglobin,0.5
blood smear finding,0.1
extrinsic allergic alveolitis,0.0
encephalitis,0.1
whole blood glucose monitoring,0.75
ganglioside gd1a igm,0.1
diabetic urinalysis protein test,0.75
occult blood test type ii,0.05
linagliptin,0.5
nateglinide,0.5
ganglioside gd1a igg,0.1
ganglioside gd1b igg,0.05
herpes simplex virus 1 igm,0.0
glucose (bedside glucometer),0.5
insulin-like growth factor binding protein 1,0.25
neuronal nuclear type 1 ab,0.0
blood type,0.0
herpes simplex virus type 1 immunoglobulin m,0.0
ml insulin isophane 100 unt/ml pen injector,0.75
secondary hypothyroidism,0.1
coxsackievirus b antibody type 1,0.3
flurbiprofen,0.0
insulin dependent diabetes mellitus,1.0
diabetes with cc,0.5
glucose dial 1,0.5
monogenic diabetes,0.5
=dextrose,0.5
type 1,0.95
glucose 1 hour challenge,0.25
glucose fasting t1c,0.5
glucose dialysis,0.5
insulin regular,0.75
insulin syrg mis 1ml,0.75
urine glucose,0.6
glucose elimination,0.5
"glucose, random",0.5
glucose_tablet,0.75
=insulinhumanregiv,0.9
insulin pump,0.9
bio liquid glucose,0.5
insulin - regular,0.9
"glucose, poc",0.5
glucose (research),0.5
glucose fasting,0.5
poct glucose,0.5
"glucose, confirmatory",0.75
hyperglycemia,0.75
alpha 1,0.0
hiv 1,0.0
body fluid glucose,0.5
hypoglycemia_protocol,0.75
dextrose pn,0.5
blood glucose,0.75
blood sugar,0.5
"glucose,syn fluid",0.5
glucagen,0.75
index 1,0.0
"glucose, ascites",0.25
glycolysis enzyme,0.1
lactate dehydrogenase 1,0.1
quantity 1,0.0
glucose level,0.5
glucose dial 2,0.5
1 lux,0.0
creatinine day 1,0.1
poc i stat glucose,0.5
igg 1 subclass,0.1
blood glucose level at time 1,0.5
"diabetes mellitus, unspecified, without complications",0.5
"diabetes mellitus, unspecified, with ketoacidosis",0.75
glucose control - prophy,0.75
glut1 deficiency syndrome,0.0
"diabetes mellitus, unspecified, with other specified complications",0.5
"diabetes mellitus, unspecified, with coma",0.5
gd1a,0.0
blood glucose test,0.75
mody genotype conclusion,0.1
blood glucose level,0.75
"diabetes mellitus, unspecified, with multiple complications",0.5
personal history of gestational diabetes,0.1
diabetes without cc/mcc,0.5
hemoglobin a1c (hgba1c),0.8
ingested glucose dose,0.5
glucose large artwork delayed,0.1
glucose tolerance fasting (do not order alone),0.5
glucose sg t10,0.5
glucose fpg,0.75
gen m.metab (1piti),0.0
"glucose tolerance, 3 hour",0.5
glucose wb neo (bkr),0.5
"glucose, ob/post dose",0.5
"glucose tolerance, 2 hour",0.5
glucose tolerance 120 min(do not order alone),0.5
average blood glucose,0.5
monogenic obesity,0.1
alpha glucosidase - blood,0.1
glucose blood time 0,0.5
glucose sg t15,0.5
glucose tolerance 30 min(do not order alone),0.5
=insulinhumanregsubq,0.9
peutz-jeghers (stk11),0.0
glucose-wb - confirmation,0.5
capillary glucose (mg/dl),0.8
disease 1 - omim number,0.5
glucose fasting t13,0.75
islet cell 512 ab | serum | serology - non-micro,0.75
insulin ab | serum | serology - non-micro,0.75
beta hydroxybutyrate | serum or plasma | chemistry - non-challenge,0.75
acetone | serum or plasma | drug toxicology,0.5
c peptide | serum or plasma | chemistry - non-challenge,0.75
hemoglobin a1c/hemoglobin.total | blood | hematology and cell counts,0.75
somatotropin | serum or plasma | chemistry - non-challenge,0.1
glucose | blood | chemistry - non-challenge,0.75
glutamate decarboxylase 65 ab | serum | serology - non-micro,0.75
pancreatic islet cell ab | serum | serology - non-micro,0.75
cramp of limb,0.1
bandage,0.05
"bandage,stretch",0.05
"other chronic ischemic heart disease, unspecified",0.1
tape,0.0
other diagnostic cardiovascular procedures,0.1
urine protein dipstick test,0.5
acquired toe deformities,0.2
insulin pump self administered,0.75
pancreatic islet cell,0.75
bd ins syr 0.3/31g/6mm hu mis,0.75
insulinhumanregrecomb250units/2.5ml,0.9
thiothixene,0.0
"personal history of noncompliance with medical treatment, presenting hazards to health",0.2
dextrose_50%_lifeshield_syringe_50_ml,0.25
b-d nano ultrfin pen ndl32gx4mm grn,0.75
ec8 gases istat venous poct (lab use only),0.1
embrace 30g lancets,0.8
volatiles and gases,0.1
bayer contor tes next,0.75
cerebral infarction due to thrombosis of bilateral vertebral arteries,0.2
consult / referral to certified diabetes educator (internal),0.75
acquired absence of left leg below knee,0.2
dextrose50%lifeshieldsyringe50ml,0.5
gelatin_sponge_12/7_mm,0.05
acanthocytes,0.05
mycophenolate mofetil,0.1
@bd insulin syr 0.5ml 31gx5/,0.75
multivitamin,0.1
kwashiorkor,0.0
personal history of systemic steroid therapy,0.1
clever choice comfort ez 31gx8mm pen,0.75
other toe(s) amputation status,0.4
novofine     mis 32g,0.75
insulinglargine1unit/0.01ml,0.75
autoshield   mis 30g,0.5
acquired absence of right great toe,0.1
epstein barr virus dna,0.1
"acquired absence of other toe(s), unspecified side",0.3
evolocumab,0.1
insulinreg100units/ns100mlpmx(cabinetuseonl,0.75
"underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter",0.75
consult / referral to diabetic educator,0.75
insulin syrg mis 0.5/29g,0.75
lancet delica one touch 30g misc,0.75
b d insulin syringe ultra 0.3/31g syn,0.75
insulin aspart protamine- and insulin aspart-containing product,0.9
Insulin human Ab,0.5
simvastatin,0.1
ivacaftor,0.0
psychogenic and somatoform disorders,0.05
secretin,0.1
noroxycodone,0.0
6-monoacetylmorphine,0.0
norhydrocodone,0.0
hydrocodone,0.05
morphine,0.05
oxymorphone,0.0
Plasminogen actual/Normal,0.1
gastroesophageal laceration-hemorrhage syndrome,0.05
Zinc transporter 8 Ab,0.9
venereal diseases due to chlamydia trachomatis,0.0
reticulin ab,0.1
reticulin iga,0.1
acute gastritis,0.1
viral hepatitis,0.1
plasminogen,0.1
tissue transglutaminase iga,0.25
antisocial/borderline personality disorder,0.0
streptococcus pyogenes ag,0.1
prenatal multivitamin,0.1
21-hydroxylase ab,0.1
acute pulmonary heart disease,0.1
carboxy tetrahydrocannabinol,0.0
gliadin ab,0.2
hemorrhage of gastrointestinal tract,0.1
posttraumatic stress disorder,0.0
pilonidal cyst,0.0
encounter for long-term (current) use of anticoagulants,0.05
chronic bronchitis,0.1
other cardiac conduction disorders,0.1
thyrotropin receptor ab,0.1
ethanol,0.1
bipolar,0.0
adrenal hypofunction,0.1
heart failure with preserved ef [diastolic heart failure],0.2
osteoporosis,0.2
myalgia and myositis unspecified,0.1
flatulence,0.05
"epilepsy, recurrent seizures, convulsions",0.05
constipation,0.1
hyperventilation,0.1
epilepsy,0.05
abnormal findings examination of lungs,0.1
e. coli,0.1
chronic sinusitis,0.05
peritonitis and retroperitoneal infections,0.1
decreased white blood cell count,0.1
persons encountering health services in circumstances related to reproduction,0.1
adverse effects of antibacterials (not penicillins),0.0
adverse effects of sedatives or other central nervous system depressants and anesthetics,0.05
hormones and synthetic substitutes causing adverse effects in therapeutic use,0.25
"potential health hazards related to communicable diseases
potential health hazards related to communicable diseases",0.0
sleep related movement disorders,0.1
osteoarthrosis nos,0.1
acquired absence of limb,0.2
cystitis,0.1
chronic pain,0.1
respiratory insufficiency,0.1
antineoplastic and immunosuppressive drugs causing adverse effects,0.1
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh],0.1
shortness of breath,0.2
occlusion of cerebral arteries,0.2
lantus,0.75
humalog,0.9
hepatobiliary diagnostic procedures with mcc,0.1
50 ml glucose 500 mg/ml prefilled syringe,0.1
cd19,0.0
"peripheral, cranial & autonomic nerve disorders",0.5
metabolic disturbance ncp - plan revised,0.5
metabolic disturbance ncp - interventions,0.4
metabolic disturbance ncp - expected outcomes,0.4
"calculated bicarbonate, whole blood",0.25
glucose 0.4 mg/mg oral gel,0.5
cranial and peripheral nerve disorders without mcc,0.1
metoclopramide 10 mg oral tablet,0.1
iabp placement confirmed by x-ray,0.05
aspirin 81 mg chewable tablet,0.1
"heparin sodium, porcine 5000 unt/ml injectable solution",0.05
blue top hold,0.0
humulin r,0.9
humulin n,0.75
green top hold (plasma),0.1
ondansetron 4 mg disintegrating oral tablet,0.05
1000 ml sodium chloride 4.5 mg/ml injection,0.1
length of urine collection,0.1
metoclopramide 5 mg oral tablet,0.1
light green top hold,0.0
epithelial cells,0.05
bacteria,0.05
rbc,0.1
wbc,0.1
lipase,0.1
ph,0.0
urine appearance,0.2
specific gravity,0.2
ketone,0.75
bilirubin,0.1
urobilinogen,0.1
nitrite,0.1
blood,0.1
dok,0.0
"sennosides, usp 8.6 mg oral tablet",0.05
haloperidol (haldol),0.0
2 ml ondansetron 2 mg/ml injection,0.05
amlodipine 5 mg oral tablet,0.1
nephrocaps,0.2
ondansetron 4 mg oral tablet,0.1
% hemoglobin a1c,0.75
"creatinine, urine",0.25
troponin t,0.1
labetalol hydrochloride 200 mg oral tablet,0.1
levemir,0.9
2 ml metoclopramide 5 mg/ml injection,0.1
uhold,0.0
"hcg, urine, qualitative",0.0
metronidazole 500 mg oral tablet,0.0
transitional epithelial cells,0.0
acetaminophen 325 mg / oxycodone hydrochloride 5 mg oral tablet,0.0
synthroid,0.1
"creatine kinase, mb isoenzyme",0.05
"release of the distal end of the catheter from an implanted infusion system for intraperitoneal insulin therapy, by laparoscopy",0.75
hba1c comment,0.75
user,0.5
serial number of the device,0.0
"actrapid insulin, novolet pen",0.9
"insulin aspart 100 u/ml (fiasp), inj sol, pen 3 ml (flextouch)",0.9
"diabetes mellitus, unspecified, with ophthalmic complications",0.5
diabetic arthropathy,0.75
"insulin humulin nph, cart",0.75
bolus if hyperglycemia >2.5g/l - insulin pump (novorapid),0.9
"glucose 10% (g10), 500 ml bag macoflex n",0.2
"insulin degludec 100 u/ml (tresiba), injection solution, cartridge 3 ml",0.75
"change of the intraperitoneal catheter of an implanted infusion system for intraperitoneal insulin therapy, by laparotomy",0.9
anti-surge reefs,0.0
"diabetes mellitus, unspecified, with renal complications",0.5
"insulin aspart 100 u/ml (fiasp), injection solution, vial 10 ml",0.9
"diabetes mellitus, unspecified, with neurological complications",0.5
myasthenic syndrome in endocrine diseases,0.1
"insulin degludec 200 u/ml (tresiba), injection solution, 3 ml pen",0.75
"polyionic (pg10), 500 ml bag macoflex n",0.1
"glucose 10% (g10), 1 l bag ecoflac",0.25
"polyionic (pg10), 1 l bag viaflo",0.1
povidone-iodine,0.1
"glucose 10% (g10), 500 ml ecoflac bag",0.25
adverse effect: insulin and oral hypoglycemics [antidiabetics],0.75
"insulin aspart 100 u/ml (fiasp), injection solution, cartridge 3 ml (penfill)",0.9
posterior sclerotomy vitrectomy with retinal endocoagulation by laser or diathermy without tamponade,0.5
"glucose 10% (g10), pe bottle 500 ml kabipac",0.2
"glucose 10% (g10), pe bottle 1 l kabipac",0.1
white mountain,0.0
presence of other specified devices,0.2
anti c21 hydroxy,0.1
"glucose 5% + potassium chloride + sodium chloride 27.5 g + 1 g + 2 g (polyionic g5 labo aguettant), sol for infusion, bag 500 ml (cosinus)",0.2
"insulin aspart 100 u/ml (fiasp), injection solution, cartridge 1.6 ml (pumpcart)",0.75
insulin antibody test,0.75
see clinical and biological assessment,0.5
"glucose 30% (g30), 10 ml ampule",0.2
adrenal insufficiency,0.1
glue (gray grade),0.0
"change of a pancreatic duct endoprosthesis, by esophagogastroduodenoscopy",0.1
"insulin glargine 300 u/ml (toujeo), inj sol, pen 3 ml (doublestar)",0.9
Islet cell 512 IgG,0.75
alb/creat ratio,0.6
znt8 autoantibodies,0.9
"glucose 30% (g30) agt, vial 10 ml",0.1
fluvastatin,0.1
rosuvastatin,0.1
ezetimibe / simvastatin,0.1
pravastatin,0.1
pitavastatin,0.1
rosuvastatin calcium 20 mg oral tablet,0.1
atorvastatin 10 mg oral tablet,0.1
pravastatin sodium 20 mg oral tablet,0.1
atorvastatin 40 mg oral tablet,0.1
rosuvastatin calcium 5 mg oral tablet,0.1
atorvastatin 80 mg oral tablet,0.1
crestor,0.1
lipitor,0.1
atorvastatin 20 mg oral tablet,0.1
pravastatin sodium 10 mg oral tablet,0.1
simvastatin 40 mg oral tablet,0.1
pravastatin sodium 40 mg oral tablet,0.1
simvastatin 10 mg oral tablet,0.1
atorvastatin,0.1
isosorbide mononitrate,0.05
bupropion,0.0
hyposmolality and/or hyponatremia,0.2
desvenlafaxine,0.05
duloxetine,0.1
venlafaxine hydrochloride,0.0
nefazodone,0.0
ferrous sulfate 75 mg/ml oral solution,0.1
railway infrastructure engineer,0.0
1 ml dry tube,0.0
"injection, insulin, per 5 units",1.0
~time in minutes,0.0
albumin excretion rate per minute,0.25
24-hour urinary albumin excretion,0.65
"dressing,polyskin ii",0.0
erythromycin_base_250mg_tab_ec_4pak,0.0
drug screen - serum/plasma,0.05
erythromycin,0.0
insulin 30gx5,0.75
"miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified",0.05
accident due to excessive cold of unspecified origin,0.0
"emollients, topical",0.05
bd ins syr 0.5/31g/6mm mis,0.85
ids_humalog_insulin_100_units/ml_3ml_(lispro),1.0
acquired absence of unspecified finger(s),0.05
buffered_lidocaine_1%_11ml,0.0
b d insulin syringe ultra- .5cc/30g syn,0.85
nephro-vite  tab rx,0.05
cerebral infarction due to thrombosis of bilateral carotid arteries,0.05
consult / referral to certified diabetes educator,0.85
freestyle    mis reader,0.2
inappropriate diet and eating habits,0.25
idsinsulinreghuman100units/ml3mlvial,1.0
drug unknown,0.0
placenta previa and abruptio placenta,0.0
"antepartum hemorrhage, abruptio placentae, and placenta previa",0.0
carditis,0.05
hemorrhage during pregnancy; childbirth and postpartum,0.0
umbilical cord complications during labor and delivery,0.05
malposition and malpresentation of fetus or obstruction,0.0
"cilazapril 2.5 mg teva, tablets",0.05
other and unspecified complications of birth; puerperium affecting management of mother,0.05
normal delivery,0.0
monitoring of an older first-time mother,0.05
late pregnancy and failed induction,0.05
maternal care for signs of fetal hypoxia,0.1
"cesarean delivery during labor, by laparotomy",0.05
alteplase,0.0
"mental disorders and diseases of the nervous system complicating pregnancy, childbirth, and the puerperium",0.1
uterine cavity revision after natural delivery,0.0
spinal anesthesia during vaginal delivery,0.05
singleton cephalic vaginal delivery in a primipara,0.05
hematocrit,0.1
single breech delivery by natural means in a multiparous woman,0.0
other high-risk pregnancy,0.1
instrumental delivery in the lower birth canal with head presentation,0.0
"abnormality of organs and soft tissues of pelvis complicating pregnancy, childbirth, or the puerperium",0.05
"scheduled cesarean delivery, by laparotomy",0.05
"immediate suture of obstetric tear of the vagina, vulva, and/or perineum [simple perineum]",0.0
monitoring of labor by a practitioner different from the one performing the delivery,0.0
pregnancy monitoring: other obstetric history and fertility issues,0.1
anatomopathological examination of a complete placenta with cord and membranes,0.0
coagulation defects complicating pregnancy or postpartum,0.05
complications of labor and delivery nec,0.05
immediate suture of obstetric perineal tear with injury to the external anal sphincter muscle [complete perineum],0.0
singleton cephalic vaginal delivery in a multipara,0.0
single breech delivery by natural means in a first-time mother,0.0
immediate suture of obstetric perineal tear with rectal injury [complicated complete perineum],0.0
reduction of severe shoulder dystocia,0.0
acute posthemorrhagic anemia,0.0
manual removal of the complete placenta,0.0
mid-cavity instrumental delivery on cephalic presentation,0.0
"fetal heart rate monitoring for more than 20 minutes, outside of labor",0.05
complications of the administration of anesthetic or other sedation in labor and delivery,0.05
screening for infectious and parasitic diseases,0.05
anion gap,0.2
iron deficiency anemias,0.05
bicarbonate,0.1
1000 ml sodium chloride 9 mg/ml injection,0.05
vitamin b12,0.05
neisseria gonorrhoeae,0.0
epoprostenol,0.01
anatomopathological examination of several complete placentas with cords and membranes,0.0
other disorders of the breast associated with childbirth and disorders of lactation,0.0
"electronic monitoring of the contractions of the pregnant uterus and/or fetal heart rate, via the uterine route",0.05
multiple natural childbirth in a multiparous woman,0.0
multiple natural childbirth in a first-time mother,0.0
"right atrioventricular valve replacement with mechanical or bioprosthetic valve with stent, via thoracotomy with cpb",0.0
transesophageal doppler echocardiography of the heart and intrathoracic vessels,0.05
deoxyhemoglobin/hemoglobin.total,0.1
primary pulmonary hypertension,0.0
fetal blood sampling from the presentation,0.05
methemoglobin/hemoglobin.total,0.05
bun/creatinine ratio,0.1
"resection of remaining lung lobe [completion pneumonectomy], by thoracotomy",0.0
"aortic valve replacement with prosthesis in non-anatomical position, by thoracotomy with cpb",0.0
"open repair of unruptured infrarenal or aorto-bi-iliac aneurysm with aorto-bifemoral prosthetic replacement, by laparotomy with suprarenal clamping",0.0
"manual ventilation of a newborn at birth, with a face mask, with intravenous administration of pharmacological agent and/or solution",0.05
thoracic and/or cardiac ct angiography,0.05
"flattening of an aorto-iliac-femoral aneurysm with bifurcated aorto-iliac-femoral prosthetic replacement, by laparotomy with suprarenal clamping",0.0
6-minute walk distance on flat ground with monitoring of oxygen saturation by transcutaneous measurement and measurement of useful oxygen flow,0.05
6-minute walk distance on flat ground with monitoring of oxygen saturation by transcutaneous measurement,0.05
hct vfr.df bldv,0.0
"ascending thoracic aorta and horizontal aorta replacement with aortic valve replacement, without reimplantation of the coronary arteries, by thoracotomy with cpb",0.05
"transthoracic echocardiography and doppler of the heart and intrathoracic vessels, with intravenous injection of ultrasound contrast agent not crossing the lung",0.05
"homolateral carotid-subclavian or carotid-axillary bypass, via cervicotomy",0.0
"removal of a palliative anastomosis for congenital heart disease, with enlargement angioplasty of a branch of the pulmonary artery, via thoracotomy with cpb",0.0
glucose bld-scnc,0.2
"renal artery thromboendarterectomy by renal arteriotomy, by laparotomy, or by lumbotomy",0.05
rubella virus vaccine live (wistar ra 27-3 strain),0.0
"left atrioventricular valve replacement with prosthesis in non-anatomical position, by thoracotomy with cpb",0.0
"coronary arteriography with angiography of a coronary bypass without left ventriculography, via transcutaneous arterial route",0.05
diphtheria-tetanus-pertussis and polio vaccination requirement [dtp + polio],0.0
"anastomosis between the pulmonary trunk and the aorta with systemic-to-pulmonary artery anastomosis, via thoracotomy with cpb",0.0
"single breath, rebreathing, or breath-hold carbon monoxide transfer measurement in the steady state",0.05
"mumps virus vaccine live, jeryl lynn strain",0.0
other deliveries with the aid of manipulation,0.0
"measles virus vaccine live, enders' attenuated edmonston strain",0.0
supraselective arteriography of the upper limb by transcutaneous arterial route,0.05
wbc # bld manual,0.0
"excision of a heart tumor, by thoracotomy with cpb",0.0
human leukocyte antigen - dr,0.2
"anterior osteotomy or total discectomy for rigid spinal deformity, with arthrodesis and instrumental correction, on 4 or more vertebrae, via thoraco-phreno-laparotomy.",0.0
"ascending thoracic aorta replacement without aortic valve replacement, with reimplantation of the coronary arteries, via thoracotomy with cpb",0.05
"resection of a ventricular wall aneurysm of the heart, by thoracotomy with cpb",0.0
"coronary revascularization with 2 arterial grafts and 3 distal anastomoses, through thoracotomy with cpb",0.05
"cannabis withdrawal syndrome: with delirium, with convulsions",0.0
implantation of a permanent pacemaker in the right ventricle via transcutaneous venous route,0.0
"pulmonary valve replacement with mechanical prosthesis or bioprosthesis with stent, via thoracotomy with cpb",0.05
"drainage of a pericardial collection, by thoracotomy or by subxiphoid approach",0.0
metformin / pioglitazone,0.1
ccs:998,0.1
pen needle,0.85
bd ins syr 0.3/31g/6mm mis,0.85
freesty libr mis 2 r,0.85
novolin r,0.9
humalog mix,0.85
novolog,1.0
humulin,0.9
anti-gad65 antibody test,0.85
pcr test for chlamydia trachomatis,0.0
"left main coronary artery enlargement angioplasty, by thoracotomy with cardiopulmonary bypass",0.05
"personal history of complications of pregnancy, childbirth, and the puerperium",0.05
"closure of a cardiac ventricular septal defect, by thoracotomy with cardiopulmonary bypass",0.0
"prolonged or resumed circulatory support by extracorporeal circulation in the operating room at the end of a cardiovascular procedure, for more than half an hour",0.05
"repair of interrupted horizontal thoracic aorta with associated intracardiac lesion repair, by thoracotomy with cardiopulmonary bypass.",0.0
single breech delivery by natural means with extraction in a primipara,0.0
carcinological histopathological examination of heart tumor resection specimen,0.0
bladder evacuation by transient catheterization [evacuative bladder catheterization],0.05
"poisoning by psychotropic substances, unspecified - school and public place",0.0
droplet ndl 32gx4mm pen,0.1
pub truetrack meter,0.1
true test blood glucose strip 100's,0.75
easy tch ndl 32gx5/32 pen,0.85
one touch ultramini meter,0.2
chlamydia trachomatis pcr test,0.0
"gastric fluid aspiration by tubing, without pharmacological test",0.05
personal history of female genital mutilation,0.0
percutaneous bone drilling or intraosseous injection,0.0
accu-chek    tes gui,0.2
repaglinide plasma,0.1
=glucagon,0.85
eag,0.0
istat  specimen type,0.0
hemolyzed sample,0.0
gamma hydroxybutyrate,0.05
pyruvate kinase,0.1
adverse effect: therapeutic gases,0.0
nc biochem lab,0.1
excessive administration of blood or other fluid - transfusion or infusion,0.05
bm conclusion,0.0
red blood cells,0.05
histamine,0.05
hemoglobin a/hemoglobin.total,0.2
Beta hydroxybutyrate + Acetoacetate,0.85
hemoglobin f/hemoglobin.total,0.1
hgb f mfr bld elph,0.05
common variants,0.1
"water for injection (labo lavoisier), solution for injection preparation, bottle 250 ml",0.05
Disaccharidases,0.1
D-Lactate,0.1
adverse effect: h2 histamine receptor inhibitor,0.05
2-methylacetoacetate,0.05
"parenteral nutrition: oliclinomel n4-550, 1.5 l bag",0.1
gamma aminobutyrate,0.05
specimen container,0.0
glucose whole blood,0.25
dextrose50%50mlvial,0.25
one,0.0
chronic hepatitis,0.0
glipizide every day,0.1
chlorpropamine quantity,0.1
healthpro glucose test str,0.25
specimen a,0.0
total hemoglobin,0.1
ethnic background stated,0.0
hemin,0.0
vascular insufficiency of intestine,0.1
3 t edta + 3 t hep,0.0
"coronary artery recanalization with stent placement, via percutaneous arterial route",0.05
polidocanol,0.0
admin interval,0.1
dextran,0.1
glucose-6-phosphate dehydrogenase control,0.1
paralytic ileus,0.05
acquired acanthosis nigricans,0.2
magnesium aspartate,0.05
reserpine,0.0
acute dermatitis due to solar radiation,0.05
potassium iodide,0.0
hetastarch,0.0
other findings,0.1
"peptic ulcer, site unspecified",0.05
frozen plasma,0.05
atrial fibrillation,0.0
gastrointestinal hemorrhage,0.05
abnormal granulation tissue,0.05
trimethoprim,0.0
dermatology pathology,0.1
noninflammatory disorders of cervix,0.0
digoxin_0.0625mg_(1/2_x_0.125mg)_tab,0.0
vitamin c,0.05
galenic ointment cnd1,0.05
captopril,0.1
reagent,0.0
collect time(hrs)+total vol. (oo),0.0
blood biochemistry,0.2
dpa1* all,0.0
"carbocisteine 2% (bronchathiol), children, oral solution, bottle 125 ml",0.0
pt,0.0
monitoring of a very young first-time mother,0.05
atrial fibrillation and flutter,0.0
dermatitis due to solar radiation,0.05
see below,0.0
ergotamine,0.05
interpreter,0.0
heart rhythm,0.05
bcg,0.0
efg donor number,0.0
triamterene,0.05
chromium,0.05
magnesium citrate,0.0
sternal fracture osteosynthesis,0.0
"excision or destruction of arrhythmogenic focus or cardioneurotic bundle for supraventricular tachycardia, by thoracotomy with cpb",0.0
"potassium canrenoate - soludactone, 100 mg/2 ml injection",0.01
"intraluminal coronary artery atherectomy, via transcutaneous arterial route",0.0
fractional flow reserve (ffr) measurement during coronary angiography,0.0
pancreatic graft harvesting from a brain-dead donor,0.1
"embolization or closure of a coronary fistula or aneurysm, by percutaneous vascular route",0.0
hla-drb1*,0.2
hla-a*,0.1
traumatic heart injury with hemopericardium without open thoracic wound,0.0
"empagliflozin+metformin hydrochloride 12.5 mg+1,000 mg (synjardy), tablet",0.25
"gastric bypass with roux-en-y anastomosis for morbid obesity, by laparotomy",0.05
"multisystem inflammatory syndrome associated with covid-19, unspecified",0.05
"adverse effect: barbiturates, nec",0.05
"imaging for interventional radiology or interventional cardiology procedure level 10, performed in an imaging room",0.0
transthoracic echocardiography and doppler of the heart and intrathoracic vessels during an intracavitary cardiac therapeutic procedure via percutaneous vascular access,0.05
"selective or superselective embolization of bronchial or pleuropulmonary artery, via transcutaneous arterial route",0.0
acute vascular insufficiency of intestine,0.1
"extrarenal purification by hemodialysis, hemodiafiltration, or intermittent hemofiltration for acute renal failure, per 24 hours",0.1
biomnis results 1,0.0
gastrojejunal ulcer,0.05
guar gum,0.1
carbamide peroxide,0.0
"poc base excess, capillary",0.1
"poc tco2, capillary",0.1
"poc po2, capillary",0.1
"poc ph, capillary",0.1
history of falling (within 3 mnths),0.1
absolute retic,0.1
estimated max conc.,0.0
"replacement of the ascending thoracic aorta and the horizontal aorta without replacement of the aortic valve, with reimplantation of the coronary arteries, by thoracotomy with cpb",0.05
"excision or destruction of arrhythmogenic focus for ventricular tachycardia, by thoracotomy with cardiopulmonary bypass",0.0
doppler ultrasound of the digestive vessels,0.05
"continuous intravenous injection of dobutamine or dopamine at a rate greater than 8 micrograms per kilogram per minute [g/kg/min], of epinephrine or norepinephrine outside the neonatal period, per 24 hours",0.05
"resection or consolidation of an infarcted myocardial zone, by thoracotomy with cpb",0.0
"horizontal thoracic aorta replacement, by thoracotomy with cpb",0.0
pericardial drainage by percutaneous approach,0.0
"adverse effect: agents primarily alpha-sympathomimetic, nec",0.05
"replacement of the descending thoracic aorta and juxtadiaphragmatic aorta, by thoraco-phreno-laparotomy with cpb",0.05
replacement of the juxtadiaphragmatic aorta by thoraco-phreno-laparotomy with cpb,0.0
red blood cell transfusion at home,0.05
"ascending thoracic aorta replacement for aneurysm rupture, by thoracotomy with cardiopulmonary bypass",0.0
"repair of supravalvular aortic stenosis, by thoracotomy with cardiopulmonary bypass",0.0
"extrarenal purification by hemodialysis, hemodiafiltration, or continuous hemofiltration for acute renal failure, per 24 hours",0.1
intraoperative transesophageal echocardiography and doppler of the heart and intrathoracic vessels for monitoring of cardiocirculatory failure following cardiopulmonary bypass.,0.05
right heart catheterization and cardiac output measurement by transcutaneous venous approach,0.05
phenylketonuria [pku],0.05
g6pd genotyping conclusion,0.05
"morphine - actiskenan, 1 mg orodispersible tablet",0.0
"cytopathologic or histopathologic examination by in situ hybridization, without signal quantification",0.0
traumatic lesion of the pleura with open chest wound,0.0
personal history of other physical trauma,0.0
high-risk pregnancy surveillance due to social problems,0.1
poc hemoglobin a1c (glycated),0.85
poct hemoglobin a1c,0.85
pain management hypnosis session,0.0
"thin or split-thickness skin autograft, sheet or meshed, on a surface area greater than 1000 cm",0.05
other assisted fertilization methods,0.05
necessity of a flu vaccination,0.2
transcatheter venous enlargement of an interatrial communication,0.0
"resection of the infrarenal, infrahepatic inferior vena cava with reconstruction, by laparotomy",0.0
"thromboaspiration of an arteriovenous vascular access of a limb with intraluminal dilation without stent placement, by percutaneous vascular route",0.05
cutaneous esophagostomy by cervicotomy,0.0
"sotrovimab - xevudy, 500mg/8ml vial inj",0.0
albiglutide,0.2
c-peptide with insulin,0.85
ids_insulin_aspart_100_units/ml_10ml,0.85
hemoglobin a1c with mpg (quest),0.85
assistance device,0.2
"partial or total adrenalectomy, by direct approach",0.05
"total adrenalectomy for pheochromocytoma, by direct approach",0.05
point of care prothrombin time,0.05
deep vein thrombosis [dvt],0.05
"surgam 200 mg, tablets",0.0
iop genetic chip,0.1
atenolol,0.05
undelivered art,0.0
corneal reflex right,0.0
vitamin e,0.05
corneal reflex left,0.0
cyclist driver - collision with stationary object - traffic,0.0
admission for observation for suspected other cardiovascular conditions,0.05
clopidogrel_75_mg_tablet,0.0
mineralocorticoid deficiency,0.1
dr+ g- ul,0.0
acebutolol,0.0
"nevus, non-neoplastic",0.0
physical force aggression - commercial zone,0.0
hpe1,0.0
esketamine,0.0
protocol colcov19 adult v2,0.0
Doravirine,0.0
right fibroscan protocol,0.0
phlebitis and thrombophlebitis of lower extremities,0.05
pulse oximetry with exercise,0.05
bacterial agents resistant to an unspecified antibiotic,0.0
dr- g+ lr,0.0
consult / referral to electrophysiology,0.05
"esophagitis, gastroenteritis and miscellaneous digestive disorders without mcc",0.05
dr+ g+ ur,0.0
dr+ p+ ur,0.0
hcv rna,0.0
dr+ p- ul,0.0
esmolol,0.05
transcutaneous abdominal ultrasound with doppler ultrasound of the digestive vessels,0.05
vitamin a,0.05
erythrocyte folates,0.05
"hiv disease resulting in malignant tumor, unspecified",0.0
hpe2,0.0
mefenamic acid,0.0
metoprolol,0.0
external beam treatment start,0.0
"general psychiatric examination, nos",0.05
warfarin,0.05
"self-poisoning by other chemicals, unspecified - collective institution",0.0
amnestic syndrome: mult drugs - other psychiatric conditions,0.0
postoperative shock,0.05
Interleukin 5,0.05
glucerna (full),0.25
digoxin,0.0
=meropenem,0.0
discharge ncp - interventions,0.1
discharge ncp - problem resolved,0.0
discharge ncp - expected outcomes,0.1
interleukin 1 beta il1b - serum,0.2
cupric oxide,0.0
hemolysis,0.05
inr(pt),0.0
muscle aches,0.05
eliquis xa activity,0.0
biomnis,0.0
sildenafil,0.01
spiritual support,0.0
free thyroxine,0.1
Fasciola hepatica Ab,0.0
file number rialism,0.0
vardenafil,0.01
hematology lab nc,0.05
avanafil,0.0
discharge ncp - plan revised,0.0
bleeding time,0.05
health gt transport,0.0
"ctelopept,du coll sg",0.0
first day cohort protection,0.0
prot light s20,0.0
parameters checked,0.95
indwelling urinary catheterization,0.05
"protein, total, pericardial fluid",0.0
prot optip s4 s48,0.0
sg servibio research,0.0
abnormal electrocardiogram [ecg] [ekg],0.05
prot light s0,0.0
pleurisy; pleural effusion,0.0
20 gauge,0.0
duodenal ulcer,0.0
plerixafor,0.05
medullary gb number,0.0
diaphragmatic hernia,0.0
ethanolamine oleate,0.0
exercise stress with perfusion imaging,0.1
fumarate,0.05
succinate,0.05
saccharide,0.05
"glucose, pleural",0.05
dosage a-d 1,0.0
commentary,0.0
lisinopril,0.05
conclusion,0.0
amlodipine,0.0
methemoglobin,0.05
ascorbic acid / copper gluconate / docosahexaenoate / eicosapentaenoate / lutein / vitamin e / zeaxanthin / zinc oxide,0.05
amlodipine / atorvastatin,0.05
time 3,0.0
inosine,0.05
amlodipine / olmesartan,0.05
ascorbic acid / biotin / folic acid / niacin / pantothenate / pyridoxine / riboflavin / thiamine / vitamin b12,0.05
amlodipine / valsartan,0.0
interpretation,0.0
clevidipine,0.0
prasugrel,0.0
alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin a / vitamin b12 / vitamin k1,0.05
nifedipine 10 mg oral capsule,0.05
adalat,0.0
nimodipine 30 mg oral capsule,0.0
amlodipine / benazepril,0.0
amlodipine 2.5 mg oral tablet,0.0
nifedipine,0.05
24 hr felodipine 2.5 mg extended release oral tablet,0.05
alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin b12 / zinc oxide,0.05
24 hr nifedipine 60 mg extended release oral tablet,0.05
nifediac,0.0
24 hr nifedipine 30 mg extended release oral tablet,0.05
norvasc,0.0
procardia xl,0.0
nisoldipine,0.0
isradipine,0.0
"manidipine 20 mg (teva lab), tablets",0.0
bicarbonates,0.1
ph temp adj bldc,0.0
patient temperature,0.0
magnesium sulfate,0.05
polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride,0.05
calcium chloride,0.0
zinc sulfate,0.05
polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride / sodium sulfate,0.05
deoxyhemoglobin,0.1
alanine / arginine / calcium chloride / dibasic potassium phosphate / glucose / glycine / histidine / isoleucine / leucine / lysine / magnesium chloride / methionine / phenylalanine / proline / serine / sodium acetate / sodium chloride / threonine / tryptophan / tyrosine / valine,0.05
ascorbic acid / polysaccharide iron complex,0.05
glucose / potassium chloride / sodium chloride,0.1
1000 ml glucose 50 mg/ml / sodium chloride 4.5 mg/ml injection,0.2
zinc chloride,0.0
chromous chloride / copper sulfate / manganese chloride / zinc chloride,0.0
magnesium chloride,0.05
sodium phosphate,0.05
magnesium sulfate / potassium sulfate / sodium sulfate,0.0
calcium chloride / lactate / potassium chloride / sodium chloride,0.0
1000 ml glucose 50 mg/ml / potassium chloride 0.04 meq/ml / sodium chloride 4.5 mg/ml injection,0.2
potassium chloride 20 meq powder for oral solution,0.05
calcium carbonate / magnesium oxide / zinc sulfate,0.0
calcium chloride / glucose / lactate / potassium chloride / sodium chloride,0.05
potassium chloride 10 meq extended release oral tablet,0.05
trophamine 10 %,0.05
potassium chloride 20 meq extended release oral tablet,0.05
alanine / arginine / aspartate / cysteine / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / sodium acetate / sodium chloride / sodium metabisulfite / taurine / threonine / tryptophan / tyrosine / valine,0.0
1000 ml glucose 50 mg/ml / potassium chloride 0.02 meq/ml / sodium chloride 9 mg/ml injection,0.25
chromous chloride / copper sulfate / manganese sulfate / selenious acid / zinc sulfate,0.05
deep sea,0.0
sodium chloride 30 mg/ml inhalation solution,0.0
"sodium phosphate / sodium phosphate, monobasic",0.05
500 ml sodium chloride 30 mg/ml injection,0.0
farm accidents,0.0
home accidents,0.0
vascular disorders of skin,0.25
hla-dqa1*,0.2
a1 microglob urine,0.2
creatinine dial 1,0.1
microorganism identification,0.05
"fio2, capillary",0.05
computer science 1,0.0
ascorbic acid / cuprous oxide / lutein / vitamin e / zinc oxide,0.05
ascorbic acid / beta carotene / cuprous oxide / vitamin e / zinc oxide,0.05
ascorbic acid / ferrous sulfate / folic acid,0.05
ascorbic acid / niacin,0.05
ascorbic acid/bioflavonoids,0.05
ascorbic acid 35 mg/ml / cholecalciferol 0.01 mg/ml / vitamin a 0.45 mg/ml oral solution,0.05
ascorbic acid / beta carotene / cuprous oxide / lutein / sodium selenate / vitamin e / zinc oxide,0.05
"heparin sodium, porcine 10 unt/ml prefilled syringe",0.05
ascorbic acid 500 mg oral tablet,0.05
ascorbic acid / iron carbonyl,0.0
cyclosporine ophthalmic product,0.05
lifitegrast,0.0
"250 ml heparin sodium, porcine 100 unt/ml injection",0.0
vitamin a/vitamin d,0.05
infuvite,0.1
acetylcysteine 200 mg/ml inhalation solution,0.0
activase,0.0
ascorbic acid / cranberry preparation,0.05
sandimmune,0.1
"500 ml heparin sodium, porcine 2 unt/ml injection",0.0
ascorbic acid / bacillus coagulans / cranberry preparation,0.05
ascorbic acid / ferrous fumarate / folic acid / vitamin b12,0.05
"heparin sodium, porcine 10000 unt/ml injectable solution",0.05
glucose / heparin,0.1
rapamune,0.05
ascorbic acid / cranberry preparation / lactobacillus sporogenes,0.05
=insulinlispro,1.0
ketone bodies (research),0.65
metFORMIN,0.2
suberate,0.0
laronidase,0.0
Pancreatic Islet Cell IgG,0.75
Alpha-1-Microglobulin/Creatinine,0.1
Alpha-1-Microglobulin,0.05
march 1,0.0
prot diamond 1,0.0
mononucleosis cell count,0.05
a1 microglob ur,0.1
information 1,0.85
Alpha-1-acid glycoprotein,0.05
monocyte lymphocyte count,0.1
family history of diabetes mellitus,0.25
analysis,0.0
adicap code,0.0
constitutional,0.0
other accidents,0.0
conclusion 1,0.85
monocytes count,0.1
misc charge,0.0
forms,0.0
laboratory - chemistry and hematology,0.1
relevant exams,0.1
"dpa nutrineal, 1.1% glucose, single luer bag 2.5l (ref dpb9674r)",0.2
filter,0.0
coronary risk profile (q),0.1
measurement of peritoneal clearances by 24-hour dialysate collection,0.05
screening for diabetes mellitus,0.5
true metrix  tes glucose,0.2
ammonia 1 {c,0.0
urea dial 1,0.05
glucose tol. 100gm 1hr,0.25
mfi adp (pac-1) t,0.0
alpha 1 antitrypsin actual/normal,0.05
diagnosis,0.0
"abnormal results of other function studies (bladder, pancreas, placenta, spleen, etc)",0.25
"metformin 1,000 mg sandoz, tablets",0.1
glucerna 1.2 (full),0.2
mfi adp (pac-1) pat,0.0
alpha 1 bio liquid,0.05
alpha 1 ur,0.05
nomenclature 1,0.0
inhaled o2 flow rate,0.05
"glimepiride, 1 mg tablet",0.2
"malnutrition-related diabetes mellitus, coma",0.2
consult / referral to diabetes self management training,1.0
class i pra,0.0
dapagliflozin propanediol,0.75
glucarpidase,0.1
miglitol,0.25
aluminum chloride,0.0
human leukocyte antigen-dqa1,0.25
glucose mg/dl,0.2
a1 patient antigen typing,0.1
apidra insulin pen,1.0
human leukocyte antigen dq alpha 1 molecular,0.25
polyarteritis nodosa,0.05
septicemia,0.05
allergic reaction to food,0.0
prednisone,0.1
lupus (localized and systemic),0.05
psoriasis,0.0
insulin - humalog,1.0
abnormal coagulation profile,0.1
alpha-1 antitrypsin deficiency,0.05
acquired partial absence of pancreas,0.2
glucose fasting blood sugar,0.75
i,0.0
amylase.pancreatic,0.1
blood glucose test strips,0.85
type 2,0.0
type 3,0.0
ectopy type 1,0.0
diet type,0.1
herpes simplex virus type 1,0.0
congenital disorder of glycosylation type ic,0.1
gd1b,0.0
blood glucose level t3,0.2
gran type i - normal,0.0
"malnutrition-related diabetes mellitus, with other specified complications",0.25
muscle dysgenesis type 1a,0.05
ett type,0.0
"malnutrition-related diabetes mellitus, neurological complications",0.2
acquired total absence of pancreas,0.85
blood glucose test t4,0.25
rbc type i - normal,0.0
t1 duration,1.0
type 1 gastric fundus dissection,0.05
body fluid ldh,0.05
evaluation of peritoneal dialysis dose by multiple blood and dialysate samples,0.05
proteins,0.05
"immunoglobulins, intravenous",0.1
hla-dq2 and hla-dq8,0.25
context,0.0
cysteamine,0.05
ascorbic acid / d-biotin / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin b12,0.05
Urea/Creatinine,0.1
carboxyhemoglobin,0.05
partial pressure of carbon dioxide in tissues,0.05
po2 bldcoa,0.0
neoral,0.1
immature granulocytes,0.05
"heparin sodium, porcine 1000 unt/ml injectable solution",0.05
ascorbic acid / ferrous fumarate / folic acid / liver stomach concentrate / vitamin b12,0.05
ascorbic acid / ferrous fumarate,0.05
riboflavin,0.05
carbohydrate to hemoglobin ratio,0.2
total nk mm,0.0
cd20 percent,0.0
cd16 mm,0.0
cd56 mm,0.05
cd45ro/ra+cd3 percent,0.05
patient facs lt#,0.0
cd10 normal control percent,0.0
ra + cd62l + cd8 normal control percent,0.05
cd56 normal control percent,0.05
cd45ro+cd3 normal control percent,0.05
lymph sum normal control,0.0
ra+cd62l+cd3 percent,0.05
cd3+cd4:cd3+cd8 ratio,0.05
patient wbc,0.05
cd2 percent,0.0
patient absolute lymphs,0.1
cd45 mm,0.0
cd3+ti gb  mm,0.1
cd20 mm,0.0
cd45+cd14+ percent,0.05
cd45+cd14+ normalcontrol percent,0.0
ra + cd62l + cd8 percent,0.05
cd45ro+cd3 percent,0.05
abnormal results of function study of liver,0.05
cirrhosis and alcoholic hepatitis with mcc,0.0
erythrocyte pyruvate kinase,0.1
request accuracy,0.95
bone marrow or stem cell transplant,0.05
family history of hepatobiliary and pancreatic diseases,0.05
differential (manual),0.0
anti-hla class i,0.1
anti-ia2 antibody test,0.85
result,0.85
to,0.0
itrinsic factor ab,0.05
foot amputation status,0.3
b d insulin syringe 1cc/30g syn,0.85
unstable angina (intermediate coronary syndrome),0.0
miconazole,0.0
"polyionic 2ag10 (pg10), bag 500 ml",0.0
asthma,0.0
creon,0.0
family history of ischemic heart disease,0.05
zolpidem tartrate 5 mg oral tablet,0.0
macrophage,0.05
metformin hydrochloride 500 mg oral tablet,0.1
papaverine,0.0
metolazone,0.05
metformin / sitagliptin,0.1
metolazone 2.5 mg oral tablet,0.05
chlorthalidone 25 mg oral tablet,0.1
metolazone 5 mg oral tablet,0.05
azilsartan / chlorthalidone,0.0
atenolol / chlorthalidone,0.1
indapamide,0.05
metformin / saxagliptin,0.1
terbinafine,0.01
Cholesterol.in LDL/Cholesterol.in HDL,0.05
linagliptin / metformin,0.2
apraclonidine,0.05
"diagnostic cardiac catheterization, coronary arteriography",0.05
chlamydia trachomatis,0.0
calcium carbonate,0.0
ciclopirox,0.0
metformin hydrochloride 850 mg oral tablet,0.1
24 hr metformin hydrochloride 500 mg extended release oral tablet,0.1
empagliflozin / metformin,0.25
citric acid / glucose / sodium citrate,0.1
iodine,0.0
eluxadoline,0.0
loperamide hydrochloride 0.2 mg/ml oral solution,0.0
loperamide / simethicone,0.0
reticulocytes,0.05
guaifenesin 20 mg/ml oral solution,0.0
mucinex,0.0
vancomycin,0.0
fentanyl,0.0
iodine/potassium iodide/zinc phenolsulfonate,0.0
cryptococcus sp ag,0.0
peripheral or central vertigo,0.05
"tetanus toxoid vaccine, inactivated",0.0
complication of colostomy or enterostomy,0.05
malignant neoplasm of ovary and other uterine adnexa,0.0
subdural hemorrhage,0.0
isoproterenol,0.05
dimethicone,0.0
peritoneal adhesions (postoperative) (postinfection),0.05
intracranial hemorrhage (injury),0.05
high-density lipoprotein cholesterol pended,0.05
intracerebral hemorrhage,0.0
dobutamine,0.05
adrenal hyperfunction,0.05
carcinoma in situ of skin,0.0
subarachnoid hemorrhage,0.0
drospirenone,0.01
gentamicin,0.0
emtricitabine,0.05
Protein S Ag actual/Normal,0.05
malathion,0.0
tricyclic antidepressants,0.05
other chylomicrons,0.05
spinal stenosis,0.0
zoster vaccine,0.0
anterior horn cell disease,0.0
"nefopam - acupan, 20 mg/2 ml amp",0.0
amantadine,0.05
collection time,0.0
"norovirus ribonucleic acid, reverse transcription-polymerase chain reaction",0.0
flecainide,0.0
benzyl benzoate,0.0
diseases due to other mycobacteria,0.0
osmolality,0.2
cerebral atherosclerosis,0.05
west nile virus igg,0.0
very low density lipoprotein fraction,0.1
nodular lymphoma,0.0
secukinumab,0.05
congenital anomalies of breast,0.0
"atrioventricular block, complete",0.05
cancer of liver and intrahepatic bile duct,0.0
heparin type,0.05
hydronephrosis,0.05
ziconotide,0.0
partial epilepsy,0.0
carboxyhemoglobin/hemoglobin.total,0.05
methyl 5-aminolevulinate,0.0
cardiac pacemaker in situ,0.05
keratoconjunctivitis,0.1
Pneumocystis jiroveci DNA,0.05
hypertrophy of female genital organs,0.05
very low density lipoprotein,0.1
acamprosate,0.0
Bictegravir,0.0
pre-dialysis,0.1
sevelamer,0.05
24-hour urine albumin test,0.65
urine osmolality,0.2
temperature,0.0
hla-dqb1*,0.3
vitamin b6,0.05
ectopic pregnancy,0.0
platelet count,0.05
elvitegravir,0.0
0.4 ml enoxaparin sodium 100 mg/ml prefilled syringe,0.0
biotin,0.05
hdl cholesterol,0.1
oliguria and anuria,0.1
cardiogenic shock,0.05
urinary tract infection,0.1
influenza,0.0
shock,0.05
ulcerative colitis,0.0
poisoning by psychotropic agents,0.0
cerebral aneurysm,0.0
eosinophilia,0.05
anticoagulants causing adverse effects,0.1
pyogenic arthritis,0.05
calculus of kidney,0.05
empyema and pneumothorax,0.0
hydrocephalus,0.0
cerebral edema and compression of brain,0.05
regional enteritis,0.05
fracture of foot,0.05
pulmonary congestion and hypostasis,0.05
urinary calculus,0.05
ascites (non malignant),0.01
cancer of esophagus,0.0
fracture of tibia and fibula,0.01
multiple sclerosis,0.0
whole blood glucose (point-of-care testing),0.85
felodipine,0.0
cardene,0.0
"lercanidipine, 20 mg film-coated tablet",0.05
"caldine 4 mg, tablets",0.0
trazodone,0.0
"supplement for the use of cinefluorography, in 35 mm during a conventional radiology examination",0.0
"supplement for the performance of a radiological examination by a mountain doctor during the diagnostic and therapeutic management of a traumatic bone and joint, musculotendinous, or soft tissue injury at the same time.",0.0
ocean brand of sodium chloride,0.0
"first-line treatment of cases requiring technical procedures (intravenous infusion, oxygen administration, cardio-respiratory resuscitation care, etc.) and prolonged presence of the physician (outside of a healthcare facility) in the following situations: - respiratory distress; - cardiac distress; - allergic distress; - acute state of agitation; - status epilepticus; - traumatic distress.",0.05
50 ml magnesium sulfate 40 mg/ml injection,0.0
control or surveillance ultrasound of fetal or maternal pregnancy pathology during a multifetal pregnancy,0.05
30 ml sodium chloride 234 mg/ml injection,0.0
"sperm retrieval from the testicle, epididymis, or vas deferens, by direct approach",0.05
50 ml sodium bicarbonate 84 mg/ml prefilled syringe,0.05
sodium chloride 0.0769 meq/ml,0.0
morphine sulfate 1 mg/ml injection,0.0
150 ml sodium chloride 9 mg/ml injection,0.05
500 ml magnesium sulfate 40 mg/ml injection,0.0
sodium chloride nasal product,0.01
calcium chloride / magnesium chloride / potassium chloride / sodium acetate / sodium chloride / sodium citrate,0.05
ascorbic acid,0.05
control or surveillance ultrasound of fetal or maternal pregnancy pathology during a singleton pregnancy,0.1
"albumin/creatinine, urine",0.25
"albumin, urine",0.25
glucose 2h pp,0.25
eprosartan,0.05
selexipag,0.0
supplement for specific examination prior and subsequent to the fitting of a mandibular advancement device in the treatment of obstructive sleep apnea-hypopnea syndrome,0.0
100 ml magnesium sulfate 40 mg/ml injection,0.0
1000 ml glucose 50 mg/ml / potassium chloride 0.02 meq/ml / sodium chloride 4.5 mg/ml injection,0.25
sodium chloride 9 mg/ml injection,0.01
contrast media supplement for intrathecal injection,0.0
magnesium chloride / potassium chloride / sodium acetate / sodium chloride / sodium gluconate,0.05
contrast agent supplement for radiographic arthrography injection,0.0
1000 ml potassium chloride 0.02 meq/ml / sodium chloride 9 mg/ml injection,0.05
100 ml potassium chloride 0.1 meq/ml injection,0.05
supplement for suprapubic injection of contrast medium for cystography,0.0
sodium chloride 1000 mg oral tablet,0.0
kay ciel,0.0
chromic chloride / copper sulfate / manganese sulfate / selenious acid / zinc sulfate,0.0
residual volume measurement supplement during standard spirometry,0.0
calcium chloride / magnesium chloride / potassium chloride / sodium acetate / sodium chloride,0.0
potassium phosphate/sodium phosphate,0.1
intravenous contrast material injection supplement during a radiographic or ct examination,0.05
citric acid / simethicone / sodium bicarbonate,0.0
glycophos,0.1
potassium chloride,0.05
calcium chloride 0.0014 meq/ml / potassium chloride 0.004 meq/ml / sodium chloride 0.103 meq/ml / sodium lactate 0.028 meq/ml injectable solution,0.05
50 ml potassium chloride 0.4 meq/ml injection,0.05
50 ml hydromorphone hydrochloride 10 mg/ml injection,0.0
dexpanthenol / magnesium sulfate / manganese sulfate / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b 12 / zinc sulfate,0.05
calcium chloride / icodextrin / lactate / magnesium chloride / sodium chloride,0.0
zinc sulfate 220 mg oral capsule,0.05
losartan,0.05
accupril,0.0
irbesartan,0.1
clinimix e 5/15,0.1
10 ml potassium chloride 2 meq/ml injection,0.05
potassium lactate,0.05
sodium bicarbonate 650 mg oral tablet,0.05
"imaging for interventional radiology or interventional cardiology procedure level 9, performed in an imaging room",0.0
mediastinal lymph node dissection supplement during pneumonectomy or lobectomy,0.0
50 ml sodium chloride 9 mg/ml injection,0.0
quantitative test for pharmacodynamic agents or allergen provocation test involving a measurement of the reactivity threshold,0.05
colyte,0.0
10 ml calcium chloride 100 mg/ml prefilled syringe,0.0
20 ml sodium acetate 2 meq/ml injection,0.05
calcium chloride 0.001 meq/ml / glucose 50 mg/ml / potassium chloride 0.004 meq/ml / sodium chloride 0.103 meq/ml / sodium lactate 0.028 meq/ml injectable solution,0.1
calcium chloride / glucose / lactate / magnesium chloride / sodium chloride,0.05
chronic pain syndrome,0.05
glucose dial 3,0.1
dexrazoxane,0.01
glucose 2 hour,0.25
"disorders of fluid, electrolyte, and acid-base balance",0.2
abnormal results of function study of kidney,0.1
oxygen device,0.05
glucose 2hr pp,0.25
diabetic educator nc,0.25
"nsfp nidrel 20 mg, tablet",0.0
ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b12 / vitamin e / zinc oxide,0.05
dna double strand,0.0
igg,0.05
babesia duncani ab,0.0
ige,0.05
interferon beta-1a,0.05
gluten ige,0.1
igs - immunoglobulins,0.1
macroglobulinemia,0.05
monocytes,0.05
igm,0.0
triglyceride,0.2
htlv i ab,0.0
fungus,0.0
mitochondria ab,0.1
insulin-like growth factor-i,0.2
dermatitis herpetiformis,0.1
parkinson's disease,0.0
beta 2 glycoprotein 1 iga,0.1
beta 2 glycoprotein 1 igm,0.1
gliadin iga,0.2
beta 2 glycoprotein 1 igg,0.1
herpes simplex virus 1 igg,0.0
candida albicans ige,0.05
thyrotropin alfa,0.05
primary biliary cirrhosis,0.0
autism,0.0
senile dementia,0.0
amiloride,0.05
dacarbazine,0.05
levocarnitine,0.1
atropine,0.0
"treatment, fracture or dislocation of hip and femur",0.05
alzheimer's disease,0.0
scopolamine,0.0
atropine / diphenoxylate,0.0
acylcarnitine/carnitine.free (c0),0.1
"rabies immune globulin, human",0.0
ancillary blood glucose level,0.75
triglycerides,0.1
easivent,0.0
urinalysis glucose test,0.65
normalized blood glucose magnesium,0.1
calculated average fasting blood sugar,0.65
urinary acetone concentration,0.75
"injection, ranibizumab, 0.1 mg",0.0
"injection, aflibercept, 1 mg, ziv-aflibercept",0.0
homatropine,0.01
quantitative microalbuminuria test,0.65
Interleukin 1 beta,0.2
corn oil,0.0
Drugs of abuse,0.0
defibrotide,0.0
intramuscular immunoglobulin,0.1
chemistry studies,0.1
DNA index,0.0
microbiology studies,0.05
dinutuximab,0.05
fatty acids,0.1
critic-aid,0.0
respiratory complications,0.2
decitabine,0.01
microcytes,0.1
therapeutic drug monitoring studies,0.2
pituitary dwarfism,0.05
schizophrenia,0.0
imiglucerase,0.0
complement c1 esterase inhibitor,0.05
autoimmune hemolytic anemias,0.1
pituitary hyperfunction,0.05
personal history of allergy to medicinal agents,0.0
nesiritide,0.05
plasminogen activator inhibitor 1,0.1
cytomegalovirus,0.05
peptide,0.2
pancrelipase,0.1
jo-1 extractable nuclear ab,0.05
Yersinia sp IgM,0.05
lactose,0.05
neurofibromatosis,0.0
Biotinidase,0.05
botulinum toxin type a,0.0
Herpes simplex virus 1+2 IgM,0.0
macadamia (macadamia spp) ige,0.05
anterior pituitary disorders,0.1
insulin-like growth factor binding protein 3,0.1
peginterferon beta-1a,0.0
gliadin igg,0.1
gingivitis,0.05
reiter's disease,0.05
dyshidrosis,0.05
Lactate dehydrogenase 1/Lactate dehydrogenase.total,0.05
aplastic anemia,0.0
dengue virus igm,0.0
borrelia burgdorferi ab,0.05
homatropine ophthalmic product,0.0
atropine ophthalmic product,0.01
open wound of finger(s),0.05
tropicamide ophthalmic product,0.05
facial weakness,0.05
open wound of hand except finger(s),0.05
carnitine,0.1
7-Dehydrocholesterol,0.05
"glucose, whole blood",0.2
dehydronorketamine quantitative,0.0
glucose-whole blood,0.25
hla class i antibody,0.1
eddp quantitative,0.05
c1 esterase inhibitor,0.05
tb 1 antigen,0.0
citric acid,0.0
nil,0.0
ige allergen cor a 1,0.05
"potassium, prime",0.05
nil rflx,0.0
other,0.0
cryocrit,0.05
neutral maltase,0.1
ipres,0.0
hla class i control cutoff,0.1
target dose,0.05
urinary incontinence,0.05
poc sed rate,0.05
genetic test,0.2
dental caries,0.05
"creatinine, fluid",0.1
camphor,0.0
collection duration,0.0
cardiac conduction disorders,0.05
hidradenitis,0.05
gastrointestinal complications,0.25
ammonia,0.0
Cell Fractions/Differential,0.1
"urea nitrogen, fluid",0.1
anti-beta 2 glycoprotein 1igg,0.1
anti-beta 2 glycoprotein 1iga,0.1
anti-beta 2 glycoprotein 1igm,0.1
average blood glucose (calc),0.75
severe combined immunodeficiency external (scid),0.05
dpc microalbumin,0.65
malignant neoplasm of uterus,0.0
recipient date of birth (mm/dd/yyyy),0.0
benign neoplasm of parathyroid gland,0.0
mental disorders durring/after pregnancy,0.1
lymphocyte,0.1
lymphocytes,0.1
granulocytes,0.1
regadenoson,0.0
beta globulin,0.1
ige allergen peanut,0.05
leukemia,0.0
gran type ii - partial flaer/cd24 deficiency,0.05
gran type iii - complete flaer/cd24 deficiency,0.05
rbc type ii - partial cd59 deficiency,0.0
alpha-1 antitrypsin,0.05
rbc type iii - complete cd59 deficiency,0.05
hypersensitivity angiitis,0.05
gp iib/iiia (epitope 1)  antibody,0.05
hodgkin's disease,0.0
thyroglobulin antibody,0.05
atropine / hyoscyamine / phenobarbital / scopolamine,0.0
"beta-2 microglobulin, urine",0.1
abnormality of gait,0.1
open-angle glaucoma,0.05
mcs b3,0.0
pseudoexfoliation glaucoma,0.0
form1,0.0
fluid amylase,0.05
urine amylase,0.1
molecular class i typing,0.05
"glucose, pleural fluid",0.05
rh type,0.0
telemed,0.0
debridement,0.1
glucose tolerance 60 min(do not order alone),0.25
"poct glucose, unsolicited",0.25
ins not linked,0.0
insulinhumanreg1unit/0.01ml,0.85
glucose tol. 100gm 3hr,0.25
alpha 1-proteinase inhibitor,0.05
hepatitis profile i,0.0
glucose-6-phosphate dehydrogenase (g6pd) deficiency without anemia,0.05
one touch verio iq bloodglucose kt,0.85
truetest     tes bld gluc,0.85
insulin syrg mis 1ml/30g,0.85
immunodeficiency due to drugs,0.05
venous blood gas glucose,0.25
c26 0,0.0
clinical info,0.0
"hla typing, celiac disease",0.25
insulin syrg mis 1ml/31g,0.85
insulin syrg mis 0.5/31g,0.85
insulin 31gx5,0.85
insulin syrg 0.5/31g mis,0.85
insulin syrg 1ml/30gmis,0.85
insulin syrg mis 0.5/30g,0.85
b d insulin syringe 1cc sht syn,0.85
insulin_human_reg_100_units/ml_1ml,0.85
insulin syrg mis 1ml/29g,0.85
insulin syrg mis 0.3/31g,0.85
hm insulin syrg 1ml 30g 5/16in,0.85
insulin syrg mis 0.3/30g,0.85
acquired absence of unspecified foot,0.1
b d pen needles ultrafine ndl orig pen,0.85
glucose - urine (point of care) (magnesium per deciliter),0.2
ketones - urine (point of care) (magnesium per deciliter),0.25
alphagan,0.05
demerol,0.0
dialysate rate,0.05
nutrition,0.25
"glucose, csf",0.1
dialysate fluid,0.05
adacel,0.0
device (vad),0.05
arch-1,0.0
macrophages,0.1
special diet,0.5
demadex,0.0
doxy,0.0
or urine,0.0
pca 1 hour limit,0.0
precedex,0.0
assist device,0.2
self adl,0.0
incision dressing #1,0.0
or sent,0.0
dilantin,0.0
ddavp,0.1
depacon,0.1
solution,0.0
x-ray,0.0
food and fluid,0.1
or received,0.0
glydo,0.0
restraint type,0.0
appetite,0.1
other cell,0.0
namenda,0.0
activity,0.0
d5 1/2ns,0.1
insulin - nph,1.0
constulose,0.0
humidification,0.05
recombivax,0.0
crrt mode,0.0
lovenox,0.05
lyrica,0.0
cough type,0.0
hiv antibody,0.0
unspecified accident,0.0
incision drainage #1,0.05
"amylase, body fluid",0.05
aicd generator procedures,0.0
ambulatory aid,0.1
turn,0.0
spont rr,0.0
dialysis catheter type,0.05
fortaz,0.0
monos,0.1
hiv 1 viral load,0.0
disorders of pancreas except malignancy with cc,0.25
disorders of pancreas except malignancy without cc/mcc,0.25
"g6pd, qualitative",0.05
pan1,0.0
boost glucose control (full),0.25
gi #1 tube mark (cm),0.0
depakene,0.0
tobacco use,0.05
"outcome of delivery, single liveborn",0.05
gi #1 tube type,0.0
quantitative g6pd,0.05
"myeloid leukemia, acute",0.0
past medical history,0.0
primary hypercoagulable state,0.05
pregnant,0.1
cancer of stomach,0.0
levothyroxine sodium 0.1 mg oral tablet,0.0
"surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation",0.05
prednisone 1 mg oral tablet,0.1
major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc,0.05
insulin - glargine,1.0
gi #1 intub site,0.0
l,0.0
cardiovascular,0.1
response,0.95
glucerna 1.5 (full),0.2
invega,0.0
white blood cells,0.05
"cholesterol, hdl",0.1
polys,0.05
nitric oxide,0.05
ectopy type 2,0.0
impaired skin #1- type,0.1
impaired skin type #1,0.05
pain type,0.0
type (tandem heart),0.0
impaired skin #2- type,0.1
impaired skin #5- type,0.1
mdi #1 drug,0.25
pressure ulcer #1- type,0.1
impaired skin #7- type,0.1
impaired skin #3- type,0.1
impaired skin type #2,0.1
response to stimuli (type),0.0
glipizide 10 mg oral tablet,0.1
impaired skin #4- type,0.1
impaired skin type #10,0.1
impaired skin type #3,0.1
impaired skin type #4,0.1
glipizide 5 mg oral tablet,0.1
dextrose 10%,0.2
impaired skin type #7,0.1
impaired skin #6- type,0.2
impaired skin type #5,0.1
1000 ml glucose 100 mg/ml injection,0.25
anti-thyroglobulin antibodies,0.2
anti-dgp (iga/igg),0.85
thyroid peroxidase antibodies,0.2
glyburide 5 mg oral tablet,0.2
1000 ml glucose 50 mg/ml injection,0.2
line type,0.0
impaired skin #8- type,0.1
malignancy of hepatobiliary system or pancreas with mcc,0.05
glyburide 2.5 mg oral tablet,0.1
atropine sulfate 0.025 mg / diphenoxylate hydrochloride 2.5 mg oral tablet,0.0
10 ml atropine sulfate 0.1 mg/ml prefilled syringe,0.0
transderm scop,0.0
cyclopentolate hydrochloride 10 mg/ml ophthalmic solution,0.01
impaired skin #3- dressing status,0.1
mastectomy procedures,0.0
donepezil hydrochloride 10 mg oral tablet,0.0
hemodialysis output,0.05
vascular dementia,0.05
impaired skin odor #3,0.05
below knee amputation status,0.25
ava line zero/calibrate,0.05
cooling device status,0.05
patient first name,0.0
donor id,0.0
gene 1,0.0
day 1: weight,0.05
liquid amylase,0.05
glucose fasting level,0.65
donor,0.0
device type,0.1
duration time 1,0.0
glucose dial 4,0.1
lactate 1c,0.05
sample nature 1,0.0
private hour t1,0.0
HIV 1 RNA tropism,0.0
cycle t1,0.1
acid maltase (acid alpha glucosidase) (pompe disease),0.0
capillary lact,0.1
serum date 1,0.0
Glucose-6-Phosphate dehydrogenase phenotype,0.1
glucose blood sugar 30 minutes,0.25
HPA-1,0.0
capillary gds,0.25
galactosemia,0.05
gd1a search,0.95
glucose fasting 12 hours,0.25
TCR alpha beta cells,0.2
lysosomal storage diseases,0.05
beta 1,0.0
beta 1 sg,0.05
biochemistry,0.1
immunology,0.1
fve title,0.0
glucagon test,0.65
title,0.0
crystals (type 1),0.1
orotic aciduria type 1,0.05
heparin-induced thrombocytopenia type 2,0.05
glucose blood test t5,0.25
glucose fasting t5 {c,0.2
sulfa.hypoglyce.uri.,0.1
biopsy,0.05
"insulin aspart, 100 u/ml, 3 ml pen",1.0
ra+cd62l+cd4 normal control percent,0.05
patient percent lymphs,0.05
sodium chloride,0.05
calcium chloride / potassium chloride / sodium chloride,0.0
aspirin / citric acid / sodium bicarbonate,0.0
"gliclazide mr 60 mg (biogaran lab), modified-release tablet",0.1
tirofiban,0.0
abciximab,0.0
treprostinil,0.01
cangrelor,0.0
eptifibatide,0.0
ticlopidine,0.0
iloprost,0.1
effient,0.0
brilinta,0.0
clopidogrel 300 mg oral tablet,0.0
veletri,0.0
clopidogrel 75 mg oral tablet,0.0
cilostazol 100 mg oral tablet,0.0
plavix,0.01
integrilin,0.0
captopril 12.5 mg oral tablet,0.1
capoten,0.1
lisinopril 2.5 mg oral tablet,0.1
"tanatril (imidapril) 10 mg, tab",0.0
"zofenil (zofenopril) 15 mg, tablet",0.0
captopril 25 mg oral tablet,0.05
lisinopril 10 mg oral tablet,0.1
lisinopril 5 mg oral tablet,0.1
enalapril maleate 5 mg oral tablet,0.1
lisinopril 20 mg oral tablet,0.1
enalapril maleate 10 mg oral tablet,0.1
dipyridamole,0.05
ticagrelor,0.01
chlordiazepoxide,0.0
hepatitis c virus igg,0.0
calcium.ionized,0.05
"cyclosporine, modified",0.1
cd10+,0.0
semaglutide,0.25
hemoglobin a1/hemoglobin.total,0.25
"acquired absence of both lower limbs [any level, except toes alone]",0.05
"glucose 10% (g10), bag 1000 ml",0.1
dutasteride / tamsulosin,0.0
hytrin,0.0
phenytoin,0.05
terazosin 5 mg oral capsule,0.0
flomax,0.0
osteopathy resulting from poliomyelitis,0.0
disopyramide,0.0
portal hypertension,0.0
tedizolid,0.0
liver abscess and sequelae of chronic liver disease,0.05
dofetilide,0.0
levetiracetam,0.0
cancer of bladder,0.0
paroxysmal ventricular tachycardia,0.0
alendronate,0.0
meropenem / vaborbactam,0.0
merrem,0.0
invanz,0.0
meropenem 500 mg injection,0.0
meropenem 1000 mg injection,0.0
cefepime,0.0
total cholesterol,0.05
levomilnacipran,0.0
alfuzosin,0.0
folate-deficiency anemia,0.05
"imipenem cilastatin (generic tienam), 500 mg/500 mg inj",0.0
obstructive chronic bronchitis,0.0
hemoglobin a2,0.1
phenylephrine,0.0
zonisamide,0.05
noxafil,0.0
daptomycin,0.0
sotalol,0.0
tamsulosin,0.0
terazosin,0.0
perampanel,0.0
magnesium,0.05
lacosamide,0.01
asthma with exacerbation,0.0
"imaging for interventional radiology or interventional cardiology procedure level 7, performed in an imaging room",0.0
intraoperative intracarotid injection supplement of radiological contrast agent for arteriography,0.0
"imaging for interventional radiology or interventional cardiology procedure level 16, performed in an imaging room",0.0
dibucaine,0.0
blood gas analysis supplement during level 3 pulmonary function testing,0.05
multiple cesarean delivery supplement,0.0
"imaging for interventional radiology or interventional cardiology procedure level 15, performed in an imaging room",0.0
supplement for performing a radiographic examination with digitized images,0.0
"imaging for interventional radiology or interventional cardiology procedure level 17, performed in an imaging room",0.0
supplement for histopathological diagnosis of malignant tumor lesions,0.0
supplement for histopathological diagnosis of tumor lesions,0.0
=nafcillin,0.0
chemotherapy,0.0
prob,0.0
ndc required ,0.0
"other vascular catheterization, not heart",0.05
ct scan abdomen,0.05
diagnostic ultrasound of heart (echocardiogram),0.05
diagnostic spinal tap,0.0
conversion of cardiac rhythm,0.05
bunionectomy or repair of toe deformities,0.0
therapeutic radiology,0.0
mammography,0.0
"other or therapeutic procedures, male genital",0.05
ureteral catheterization,0.0
nephrotomy and nephrostomy,0.05
electrographic cardiac monitoring,0.05
"hysterectomy, abdominal and vaginal",0.0
other or therapeutic procedures on bone,0.0
"incision of pleura, thoracentesis, chest drainage",0.0
"diagnostic procedures on nose, mouth and pharynx",0.0
other non-or therapeutic procedures on musculoskeletal system,0.0
"transurethral excision, drainage, or removal urinary obstruction",0.0
"treatment, facial fracture or dislocation",0.0
cancer chemotherapy,0.0
"treatment, fracture or dislocation of lower extremity (other than hip or femur)",0.05
intraoperative cholangiogram,0.0
small bowel resection,0.05
cerebral arteriogram,0.05
insertion of catheter or spinal stimulator and injection into spinal canal,0.05
arterio- or venogram (not heart and head),0.0
extracorporeal circulation auxiliary to open heart procedures,0.0
other non-or therapeutic procedures on respiratory system,0.0
arterial blood gases,0.1
electroencephalogram (eeg),0.05
appendectomy,0.0
cardiac stress tests,0.05
diagnostic bronchoscopy and biopsy of bronchus,0.0
swan-ganz catheterization for monitoring,0.0
other therapeutic procedures on muscles and tendons,0.05
endoscopy and endoscopic biopsy of the urinary tract,0.05
colorectal resection,0.0
bone marrow biopsy,0.0
other or procedures on vessels other than head and neck,0.05
other non-or therapeutic procedures of urinary tract,0.05
"gastrostomy, temporary and permanent",0.05
mastectomy,0.0
other or procedures on vessels of head and neck,0.05
respiratory intubation and mechanical ventilation,0.05
esophageal dilatation,0.05
other or therapeutic procedures on skin and breast,0.05
"thyroidectomy, partial or complete",0.05
ct scan chest,0.0
"extracorporeal lithotripsy, urinary",0.0
alcohol and drug rehabilitation/detoxification,0.0
myelogram,0.01
decompression peripheral nerve,0.05
routine chest x-ray,0.01
"aortic resection, replacement or anastomosis",0.0
colonoscopy and biopsy,0.0
lens and cataract procedures,0.1
other or heart procedures,0.05
"insertion, revision, replacement, removal of cardiac pacemaker or cardioverter/defibrillator",0.0
ileostomy and other enterostomy,0.05
contrast arteriogram of femoral and lower extremity arteries,0.1
percutaneous transluminal coronary angioplasty (ptca),0.05
arthroplasty knee,0.01
proctoscopy and anorectal biopsy,0.0
heart valve procedures,0.0
"oophorectomy, unilateral and bilateral",0.0
coronary artery bypass graft (cabg),0.05
arthrocentesis,0.0
"insertion, replacement, or removal of extracranial ventricular shunt",0.0
endoscopic retrograde cannulation of pancreas (ercp),0.05
"tracheostomy, temporary and permanent",0.0
spinal fusion,0.0
bone marrow transplant,0.05
other diagnostic procedures on musculoskeletal system,0.0
"incision and drainage, skin and subcutaneous tissue",0.05
other or therapeutic procedures of urinary tract,0.05
cholecystectomy and common duct exploration,0.0
"calcium, total",0.05
cholecalciferol 0.025 mg oral tablet,0.05
estimated gfr (mdrd equation),0.1
25-oh vitamin d,0.1
"sennosides, usp 1.76 mg/ml oral solution",0.0
"excision, lysis peritoneal adhesions",0.0
red blood cell concentrate transfusion of a volume less than half a blood mass,0.05
"bilateral total arthrectomy and/or posterior osteotomy for rigid spinal deformity with arthrodesis, instrumental correction, and anterior transpedicular osteotomy, on 6 to 9 vertebrae, via posterior approach",0.0
abdominal paracentesis,0.05
nordiazepam,0.0
oxygen saturation,0.05
iron,0.05
other or upper gi therapeutic procedures,0.05
base excess,0.1
alpha-1-fetoprotein,0.05
phosphate,0.05
choriogonadotropin (pregnancy test),0.05
aldosterone,0.05
transurethral resection of prostate (turp),0.0
immunoglobulin light chains.kappa/immunoglobulin light chains.lambda,0.05
color,0.0
prolactin,0.05
oxazepam,0.0
granular casts,0.05
exploratory laparotomy,0.0
choriogonadotropin.beta subunit (pregnancy test),0.05
electrocardiogram,0.05
25-hydroxyvitamin d3,0.05
need authorization,0.0
other therapeutic procedures,0.2
"microscopic examination (bacterial smear, culture, toxicology)",0.05
percentage of variability in other lab tests,0.05
nutritional counseling,0.65
acquired absence of right foot,0.05
deprecated hdlc serpl-mcnc,0.0
deprecated ldlc serpl-mcnc,0.05
deprecated vldlc serpl-mcnc,0.0
dantrolene,0.0
other cardiomyopathy,0.1
cephradine,0.0
inhibin,0.05
delay in sexual development and puberty nec,0.2
estriol.unconjugated,0.0
fracture of lower limb,0.05
levothyroxine,0.05
doxazosin,0.0
fracture of ankle and foot,0.05
alkaline phosphatase.bone,0.0
renin,0.1
encounter for long-term (current) use of antibiotics,0.05
excision of skin lesion,0.05
low density lipoprotein cholesterol,0.1
high density lipoprotein cholesterol,0.1
other sprains and strains,0.0
arginine,0.05
goserelin acetate,0.05
cotton ball,0.0
varicose veins of lower extremity,0.05
urinary creatinine and neutrophil count,0.1
seborrheic keratosis,0.0
other therapeutic ear procedures,0.0
arthropathy nos,0.1
viral warts & hpv,0.0
acquired absence of unspecified great toe,0.05
one touch ultra control sol,0.85
line lock,0.0
pancreas replaced by transplant,0.85
clever choice comfort ez 32gx4mm pen,0.1
bk polyoma virus plasma quant,0.0
unspecified level lower limb amputation status,0.2
schedule foot/ankle surgery,0.2
human leukocyte antigen crossmatch report,0.05
freestyle,0.1
=desmopressin,0.1
mannitol25%vial50ml,0.1
"lymphocyte immune globulin, anti-thymocyte globulin",0.1
consult / referral to durable medical equipment,0.25
dextrose_10%_/0.9%_nacl_1000_ml,0.2
renal transplant post-op long lab set,0.1
valganciclovir,0.01
"urea nitrogen, whole blood isotope dilution mass spectrometry",0.05
hematocrit instant analysis test,0.1
venous blood gas (icu),0.1
carbon dioxide,0.0
rabbit anti-human t-lymphocyte globulin,0.05
great toe amputation status,0.1
=antithymocyte_(thymoglobulin),0.05
biopsy of kidney,0.05
testosterone free,0.05
cyclic citrullinated peptide igg,0.05
cyclic citrullinated peptide ab,0.05
desogestrel / ethinyl estradiol,0.0
amikacin,0.0
"anxiety, phobic and dissociative disorders",0.05
solitary pulmonary nodule,0.0
poisoning/allergy of sulfonamides,0.0
allergy/adverse effect of penicillin,0.0
irritable bowel syndrome,0.0
degeneration of intervertebral disc,0.0
attention deficit hyperactivity disorder,0.0
spondylosis without myelopathy,0.0
"paroxysmal tachycardia, unspecified",0.05
bundle branch block,0.05
hyperplasia of prostate,0.0
chronic airway obstruction,0.05
osteoarthritis; localized,0.0
pain in limb,0.1
other specified cardiac dysrhythmias,0.05
sciatica,0.0
heart failure with reduced ef [systolic or combined heart failure],0.05
insomnia,0.05
back pain,0.05
iron deficiency anemia secondary to blood loss (chronic),0.05
"poisoning by analgesics, antipyretics, and antirheumatics",0.05
retention of urine,0.1
pain in joint,0.05
edta hold,0.0
tidal volume,0.0
urine mucous,0.05
omeprazole 20 mg delayed release oral capsule,0.0
amorphous crystals,0.0
ferritin,0.1
"iron binding capacity, total",0.05
gabapentin 100 mg oral capsule,0.0
"tissue transglutaminase ab, iga",0.2
problem specimen,0.0
gabapentin 400 mg oral capsule,0.0
permanent pacemaker mode,0.0
neutrophils,0.05
basophils,0.05
eosinophils,0.05
mcv,0.05
mchc,0.1
rdw,0.1
mch,0.05
gabapentin 300 mg oral capsule,0.0
calcium carbonate 500 mg chewable tablet,0.01
red blood cell disorders without mcc,0.05
dextrose 50%,0.25
bisacodyl 5 mg delayed release oral tablet,0.0
other acute and subacute forms of ischemic heart disease,0.1
"kayexalate 2.5g/dose, bottle 45g (prep)",0.1
"extracapsular cataract extraction by phacoemulsification, with implantation of an artificial lens in the posterior chamber of the eye",0.2
"retinovitreal surgery involving at least 4 of the following procedures: coagulation, vitrectomy, laser endocoagulation, retinotomy, internal tamponade, fluid-gas exchange, membrane peeling, retinectomy.",0.75
addition of validators,0.0
injection of pharmacologic agent into the vitreous body,0.1
"eurobiol 25,000 iu, capsule",0.05
"rilmenidine 1 mg mylan, tablets",0.0
manual extracapsular cataract extraction with implantation of an artificial intraocular lens in the posterior chamber of the eye,0.1
"injection of inert or organic substance into the anterior chamber of the eye, via transcorneal route [reformation of the anterior chamber]",0.0
ticarcillin,0.0
citrated tube/plate,0.0
brimonidine,0.01
doripenem,0.0
epiretinal membrane and/or vitreous [hyaloid] membrane dissection,0.05
research chromatography column,0.0
"glucose 2.5% (g2.5%), 1 l ecoflac bag",0.1
nc blood sheet,0.05
"naftidrofuryl - praxilene, 200 mg tablets",0.0
endoscopic biliary sphincterotomy,0.0
first name subject exposed,0.0
acetylcysteine,0.0
"oxybuprocaine, 1.6 mg single-dose eye drops",0.0
nicardipine,0.05
fluorescein / proparacaine,0.05
nimodipine,0.05
ferrous gluconate,0.05
albumin/protein.total,0.1
other diagnostic ultrasound,0.05
proparacaine hydrochloride 5 mg/ml ophthalmic solution,0.0
"magnesium chloride / potassium chloride / potassium phosphate / sodium acetate / sodium chloride / sodium gluconate / sodium phosphate, dibasic",0.05
potassium acetate / potassium bicarbonate / potassium citrate,0.05
klor-con,0.1
calcium carbonate / magnesium chloride,0.0
5 ml lidocaine hydrochloride 20 mg/ml prefilled syringe,0.0
calcium chloride 0.0014 meq/ml / glucose 50 mg/ml / potassium chloride 0.024 meq/ml / sodium chloride 0.103 meq/ml / sodium lactate 0.028 meq/ml injectable solution,0.1
20 ml potassium chloride 2 meq/ml injection,0.05
sodium acetate,0.05
"imaging for interventional radiology or interventional cardiology procedure level 22, performed in an imaging room",0.0
capsaicin / lidocaine / menthol / methyl salicylate,0.05
golytely,0.0
calcium chloride / fibrinogen / fibrinolysis inhibitor / thrombin,0.0
omeprazole / sodium bicarbonate,0.0
generic code,0.0
laboratory comment,0.0
other laboratory,0.1
hemoglobin.gastrointestinal,0.0
timepc,0.0
po intake,0.1
allergen,0.0
urine urea,0.1
pca medication,0.1
time duration 7,0.0
neupogen,0.0
advanced maternal age,0.05
farr test,0.1
fasting status,0.1
single pregnancy care,0.05
iron overload,0.05
secondary diagnosis,0.0
factor 7,0.05
resistance profile 1,0.1
beta tester,0.0
resistance profile 2,0.1
down syndrome,0.0
t4 duration,0.05
o2 capacity,0.05
anserine,0.0
latent tuberculosis,0.0
pco2,0.01
incision check,0.0
acc research,0.0
required o2,0.0
ana screen,0.05
nursing orders 2,0.0
trach care,0.0
myelemia,0.0
chronic cough,0.0
psv level,0.05
potassium ur,0.05
disorders of accommodation,0.05
t3 duration,0.05
po2,0.0
mental status evaluation,0.1
patient body temperature,0.05
risk factor calculation,0.1
long qt,0.05
pre-admission,0.05
vitamin b2,0.05
phobia,0.0
anca test,0.1
mitomycin,0.0
neomycin,0.0
carbachol,0.0
temperature-sensitive patient,0.1
time ratio 2,0.0
factor 13,0.0
ena screening,0.1
sodium dial 1,0.05
nursing orders 3,0.0
sodium ur,0.05
t5 duration,0.0
t6 duration,0.0
used device people,0.0
transport chair,0.0
physician comment,0.0
closed thumb fracture,0.0
calciuria,0.1
patient under treatment,0.1
birch v1,0.0
polymyositis,0.05
tf-witness1,0.0
etomidate,0.0
cancer of larynx,0.0
other specified infectious diseases,0.0
4-anti dipole,0.0
ropinirole,0.0
accidental fall from bed,0.0
athena m1 prototype,0.0
amoxapine,0.0
pnp2 patient,0.0
desogestrel,0.0
vascular disorders of penis,0.1
12-hour creatinine,0.1
2 hour postprandial blood glucose,0.85
treatment = none,0.0
f256 nuts,0.0
cisatracurium,0.0
benign neoplasm of colon,0.0
hm ii- flow,0.0
vibegron,0.0
gi prophy,0.05
howtohla,0.0
cancer of tongue,0.0
neckerparis,0.0
personal history of contraception,0.0
heptimax trademark,0.0
family history of anemia,0.0
cancer ag 125,0.0
mustard f89,0.0
benign neoplasm of uterus,0.0
lactated ringer's,0.05
ectopy frequency 1,0.0
tinidazole,0.0
gds commentary,0.0
cancer of mouth,0.0
pnp1 patient,0.0
=verapamil,0.0
date of surgery,0.0
interferon a s dose,0.05
=digoxin,0.0
1 egg white,0.0
vitamin d,0.1
vap - prophy,0.05
megestrol,0.01
hallux rigidus,0.0
personal history of anaphylaxis,0.05
esa supporting dx,0.1
patient location,0.0
clozapine,0.01
adenovirus type 40/41,0.0
primary site cancer,0.0
tikosyn,0.0
imipramine+desipramine,0.0
trileptal,0.0
risk for falls,0.1
interleukin 6,0.1
copper,0.0
meningococcal vaccine b,0.0
erythema nodosum,0.05
difficulty in walking,0.2
polymyalgia rheumatica,0.0
urine glucose- ketonuria,0.75
creatinine dial 2,0.1
ery-tab,0.0
lancets sterile  30g (lrd),0.2
insulin-like growth factor 2,0.1
dextrose 5% and water,0.2
dextrose 50% and water,0.25
dextrose 20% and water,0.2
other physical therapies,0.1
presence of other specified functional implants,0.05
"doxium 250 mg, tablets",0.0
prochlorperazine 25 mg rectal suppository,0.0
"ace elastic bandage 4""",0.0
check-up examination after other treatments for other conditions,0.1
anti-znt8 assay,0.85
p-total protein intact,0.05
complementary conclusion,0.0
alcohol withdrawal,0.0
procedure and treatment not carried out because of patient's decision for reasons of belief and group pressure,0.0
therapy,0.1
prot biopark screen,0.05
urine white blood cell count with clumps,0.1
ehrlichia chaffeensis igg,0.0
hospital preparation: dexamethasone 5mg capsule,0.05
gitelman syndrome,0.1
pheresis catheter type,0.05
"repair of tetralogy of fallot with pulmonary ring section, by thoracotomy with cpb",0.0
chlamydia trachomatis+neisseria gonorrhoeae dna,0.0
total number of etv6-pdgfrb,0.0
"coronary revascularization with venous graft and 3 distal anastomoses, through thoracotomy with cpb",0.05
monocyte count automated,0.05
b-d #8440 s/n 0.3ml 31gx5/16 1/2unt,0.0
encounter for sterilization,0.0
=nitroglycerin,0.0
traumatic injury of muscles and tendons of unspecified part of body,0.0
"arterial pco2 calculated, relocated",0.0
shampoo,0.0
"reduction of a dislocation of the metacarpophalangeal or interphalangeal joint of a finger, by arthrotomy",0.0
10-hydroxycarbazepine,0.0
sars-cov-2 antibody,0.01
"inhalation, ingestion foreign bodies - respiratory obstruction - unspecified place",0.0
11-Deoxycorticosterone,0.05
fracture of upper limb,0.05
creatine kinase (ck),0.05
igg subclass 4,0.05
100 ml metronidazole 5 mg/ml injection,0.0
proximal phalanx osteotomy and mobilizing release of the first metatarsophalangeal joint,0.05
0.8 ml enoxaparin sodium 100 mg/ml prefilled syringe,0.0
1 ml phenylephrine hydrochloride 10 mg/ml injection,0.0
hepatitis c virus rna,0.0
inguinal and femoral hernia procedures with cc,0.0
platelet function test,0.05
htt gene cag repeats,0.1
rye (secale cereale) ige,0.05
3rd tube backup fuel unit,0.0
"carcinological purpose anatomopathological examination of glossectomy, buccal pelvectomy, pelviglossectomy, or oropharyngectomy without mandibulectomy specimen",0.0
alginic acid/al hydroxide/mg trisilicate,0.05
"dressing,covaderm",0.05
amorphous urinary sediment,0.05
somatropin,0.2
ra hemorrhoidal cream,0.0
light chains command,0.0
prot csl842-1 d1-196,0.0
estimated platelet count,0.05
Anacardium occidentale recombinant (rAna o) 3 Ab.IgE,0.05
parvovirus b19 dna,0.01
"fine needle aspiration of lymph node, percutaneous without guidance",0.0
glutamic acid + glutamine blood test,0.2
smpr b,0.0
human papilloma virus 16 dna,0.0
human papilloma virus dna,0.0
serum sodium,0.1
"parenteral nutrition: oliclinomel n7-1 000, 2 l bag",0.1
cfu-mk (per 10^5 cells),0.0
collagen 2g/ml,0.0
fresubin original fiber (en/pn/f),0.1
oxygen partial pressure at 50% hemoglobin saturation,0.05
magnesium_sulfate_40_gm/l_bag,0.05
threonine,0.0
"estrogens, esterified (usp) / methyltestosterone",0.0
phencyclidine concentration,0.0
herpes simplex virus 2 ab,0.0
electrolytes 1998 panel,0.1
"measurement of motor conduction velocities and muscle response amplitudes of 5 or more nerves, without proximal conduction study",0.05
lower limb telemetry by ct scan,0.05
prot evercmv s3>11,0.0
difficulties related to possible physical abuse inflicted on a child,0.0
reason for referral:find:pt:^patient:nar: :,0.0
lymphocyte percentage,0.1
"fabrication of a rigid pelvibifemoral, pelvibicrural [pelvibijambier], or pelvibipedal immobilization device",0.05
"renal artery recanalization with stent placement, by percutaneous arterial route",0.05
contact radiotherapy treatment protocol for malignant disease,0.0
"selective or superselective embolization of the testicular or ovarian vein, via transcutaneous venous approach",0.0
"partial resection of the tibia and/or fibula without interruption of continuity, through multiple approaches",0.0
"iron - ferinject, 100 mg/2 ml inj sol",0.0
3-Hydroxypropionate/Creatinine,0.05
Cells.cytoplasmic CD3/100 cells,0.05
"gefitinib, oral, 250 mg",0.0
one tch ultr ctl2x4ml sol,0.1
"physical therapy exercises, manipulation, and other procedures",0.1
pco2 bldcoa,0.0
poc mpaw,0.0
beta alanine,0.05
multiple valvular involvements in diseases classified elsewhere,0.0
"doppler ultrasound of the abdominal aorta, its visceral branches, and the iliac arteries",0.05
hydroxylysine random urine,0.05
pain and other symptoms associated with female genital organs,0.05
pcr flu a h3/liq b,0.0
albumin 5%,0.1
=d5lr+kcl20meq,0.0
adverse effect: other analgesic and antipyretic drugs,0.05
treatment,0.0
Contactin-associated protein 2 IgG,0.1
blood removed from patient,0.05
mfi (gp2b)    pat,0.0
Bovine serum albumin (BSA) IgE,0.05
"dogmatil 100 mg/2 ml, inj sol, amp",0.0
acti-lance,0.0
"viral culture, herpes",0.0
"blow, twist, bite or scratch inflicted by a third party - home",0.0
hb a%,0.1
eli-pra screen,0.05
spironolactone 3 mg capsule,0.0
lyme disease-fluid type,0.0
prot gastrim t15>120,0.05
streptococcus agalactiae dna,0.0
Chylomicrons/Lipoprotein.total,0.05
adamts 13 activity (tt),0.0
barbiturates serum quantitative,0.0
scl 70 titration,0.0
prot evercmv m3,0.0
methenamine,0.0
"sars-cov-2 (covid-19) vaccine, mrna spike protein",0.05
long-term vka,0.05
oseltamivir,0.0
open reduction and internal fixation of fractures of multiple bones of the hand involving the joint,0.05
pressure ulcer #4- odor,0.05
immature granulocyte percentage,0.05
3-methylhistidine/creatinine,0.05
promote_rtu_1000ml,0.0
listeria monocytogenes ab,0.05
factor viiic 1/40,0.0
riker-sas scale,0.0
alpha-1-antitrypsin,0.05
total volume of urine,0.1
occult blood fecal immunochemical test #3 of 3,0.0
prescription date,0.0
emotional / physical / sexual harm by partner or close relation,0.0
charcot-marie-tooth,0.0
recurrent pterygium excision without autograft,0.0
=flumazenil,0.0
acquired absence of left foot,0.05
candida glabrata dna,0.05
adverse effect: other antipsychotics and neuroleptics,0.05
phenylephrine20mg/ns250mlpremix(donotuse),0.0
cfu-e (per 10^6 cells),0.0
macrophages/100 leukocytes,0.05
urine chloride concentration,0.1
initial surgical dressing of a burn on the head,0.0
sulfamethoxazole,0.0
sepsis and sirs,0.05
Neutrophils/100 cells,0.05
plasma potassium(k),0.1
hematology analysis name,0.05
metaphase chromosome hybridization (two or more probes),0.05
impaired skin  - dressing status #3,0.1
cholesteatoma excision with closed technique tympanoplasty and ossiculoplasty,0.0
multi lumen line tip cultured,0.05
serotonin,0.05
torsemide 20 mg oral tablet,0.05
surgicelnu-knit6x9sponge,0.0
paris (1 small),0.0
total serum protein,0.1
extended ckd,0.2
diuril,0.0
very long chain fatty acids,0.1
aveenobar_normal-dry_soap_90_gm,0.0
gpiiia (y2/51),0.0
altered respiratory status ncp - goal,0.05
"escitalopram, 10 mg scored tablet",0.0
permanent cardiac pacemaker implant with cc,0.0
estimated platelet count concentration,0.05
methanol,0.0
casein ab.ige.rast class,0.05
"arterial switch operation for transposition or malposition of the great arteries with closure of a ventricular septal defect, via thoracotomy with cardiopulmonary bypass",0.0
"pathological, developmental or recurrent dislocation",0.0
2 right arm spans,0.0
untethering of the spinal cord via posterior approach,0.0
rhinovirus+enterovirus rna,0.05
b51 gene search,0.1
urine culture and urinalysis,0.1
time 8,0.0
fosamprenavir,0.01
"normal human ig - privigen, 10 g/100 ml inj",0.05
"motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle",0.0
factor viii chromogenic,0.0
equipment,0.1
other antibiotic,0.0
"aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure",0.05
"fall, being carried or supported by others - home",0.05
restraint device (violent),0.0
ursodiol,0.0
"mri of 3 or more segments of the spine and its contents, without intravenous contrast injection",0.0
sanger sequencing for point mutation detection,0.1
consult / referral to comprehensive breast center,0.0
serine protease,0.05
packed erythrocytes units available,0.0
Calcium.ionized/Calcium.total,0.0
alloisoleucine,0.05
anti m2 mitochondrial ab - igg,0.1
zidovudine,0.0
aspirin / oxycodone hydrochloride / oxycodone terephthalate,0.0
rozerem,0.0
lymphocytic choriomeningitis virus igg,0.0
white birch (betula populifolia) ige,0.0
non-traumatic intracerebral hematoma evacuation by craniotomy,0.0
anti-nf 186 antibodies,0.1
bictegravir / emtricitabine / tenofovir alafenamide,0.0
"buprenorphine screen, urine",0.05
"closure of spina bifida with myelomeningocele, via posterior approach",0.0
baclofen 10 mg oral tablet,0.0
"surfactant deficiency, congenital protein",0.05
urinary creatinine and magnesium per deciliter,0.1
predicted glomerular filtration rate,0.2
serum chloride concentration,0.1
matutes score,0.05
"bilateral total arthrectomy and/or posterior osteotomy for rigid spinal deformity with arthrodesis and instrumental correction, on 10 or more vertebrae, via posterior approach",0.0
"macrogol (generic forlax 4 g), sachet (pediatric use only)",0.0
nailfold capillaroscopy,0.1
self-inflicted injury by unspecified means - home,0.05
250 ml glucose 100 mg/ml injection,0.2
total carnitine,0.1
consult / referral to vascular surgery,0.1
mature basophils percentage,0.05
laparoscopic posterior hysteropexy [promontofixation],0.0
"destruction of several foci and/or interruption of several ventricular arrhythmogenic circuits with radiofrequency current, by transcutaneous vascular route",0.0
epstein barr virus nuclear ab,0.05
Latex recombinant (rHev b) 5 IgE,0.05
treponema pallidum ab,0.0
other laboratory controls,0.1
"catheter,external",0.1
mutated gck gene,0.1
"pedal cycle driver injured in noncollision transport accident in traffic accident, subsequent encounter",0.0
bee rapid api 214 square meters,0.0
arctic sun/alsius set temp,0.05
"recanalization of an upper limb artery with placement of a covered stent, via transcutaneous arterial route",0.05
14 g phlebitis scale,0.0
acetazolamide 250 mg oral tablet,0.0
jc virus dna,0.01
urea dial 3,0.1
pnn flaer-/cd24- (types 2 and 3),0.0
mid-cell percentage - predicted,0.0
serum collected on,0.0
cd2 cells nfr bld,0.05
blood product unit id,0.0
HIV 2 gp36 Ab,0.0
dry pellet packaging,0.0
aspartate,0.1
dexcom g6    mis tra,0.9
"coronary revascularization with 2 arterial grafts and 2 distal anastomoses, through thoracotomy with cpb",0.05
"other urethral stricture, male, unspecified site",0.0
normoblasts nfr mar manual,0.0
"calcium heparin (generic calciparine), 5,000 iu/0.2 ml injection",0.0
g6pd/pk ratio,0.05
"t(9;22)(q34.1;q11)(abl1,bcr) b2a2+b3a2 fusion transcript/control transcript (international scale)",0.0
sodium ur tp,0.05
factor xii 1/10,0.0
screening for other and unspecified deficiency anemia,0.05
knee disarticulation,0.0
pbiom receptor,0.05
one touch suresoft lancing dev/gent,0.2
ana test result,0.1
"resection of a cervical rib, via supraclavicular approach",0.0
pathology findings,0.1
"hand or wrist procedures, except major thumb or joint procedures with cc/mcc",0.0
thrombin time,0.05
clostridioides difficile bi-nap1-027 strain dna,0.0
"coveram 5 mg/10 mg, aip mwi ro tablets",0.0
Lymphocyte subset interpretation,0.1
consent y/n,0.0
nocardia observation (1crou),0.0
excision of a lip extending over one or more adjacent units,0.0
accidental fall from or out of building or other structure,0.0
anti-caspr2,0.05
o2 saturation measurement,0.05
uric acid,0.05
hemoglobinopathies,0.05
"poc base excess, arterial",0.05
metapneu/biop pcr,0.0
ps sequencing,0.0
magic_swizzle_liquid_180_ml,0.0
"adverse effect: adrenergic neuron blocking and centrally acting agents, nca",0.05
triiodothyronine.reverse,0.05
amylase / cellulase / lipase / protease,0.05
unilateral mammography,0.0
von willebrand factor antigen,0.05
"bazedoxifene / estrogens, conjugated (usp)",0.0
hysteroscopic myomectomy,0.0
alanine,0.05
"activity, other involving exterior property and land maintenance, building and construction",0.0
abacavir,0.0
jevity,0.0
limoges porcelain,0.0
Aspergillus sp Ab,0.05
chikungunya blood pcr,0.0
diclofenac,0.0
automated white blood cell count,0.05
reptilase time,0.0
igg on b cells (cmf),0.2
"malignancy, male reproductive system with mcc",0.0
ra+cd62l+cd4 percent,0.05
bactrim (smx/tmp),0.0
urethral meatoplasty with preputial or skin flap in adults,0.0
s of melatonin over 4h,0.0
"fracture of orbital roof, right side, subsequent encounter for fracture with routine healing",0.0
blend screen ratio,0.0
micromethod sampling,0.05
cd10,0.0
citric acid 66.8 mg/ml / sodium citrate 100 mg/ml oral solution,0.01
skull vault tumor resection with cranioplasty,0.0
dexmethylphenidate,0.0
"ibuprofen 200 mg (spifen), tablets",0.0
"ph, daily urine",0.1
hhv6 pcr/blood,0.05
actos,0.2
arctic sun temp #1 location,0.0
renacidin soln,0.0
creatine/creatinine,0.1
"vancomycin1,250mg/ns250mlpremix",0.0
human leukocyte antigen b molecular,0.1
excess base ecf,0.1
non-transfixing excision of a lesion of the skin of the nose or nasal mucosa,0.0
colchicine,0.0
urinary dipstick protein test,0.2
lidocaine topical,0.01
candida sp iga,0.05
nut ent pedia : nutrini max energy fibre  (he/np/f),0.2
"partial glossectomy of the mobile tongue, via intraoral approach",0.05
study fk 506,0.0
nasopharyngeal swab,0.01
hydroxyproline/creatinine,0.05
huntington dpn(it15),0.0
nucleated red blood cell percentage,0.05
acute febrile mucocutaneous lymph node syndrome (kawasaki disease),0.0
"internal fixation of fracture of the intercondylar eminence of the tibia [of the intercondylar tubercles] [of the tibial spines], by arthrotomy",0.0
"pre-operative examination, unspecified",0.05
pnp2 ratio,0.05
"subcutaneous tissue biopsy above the fascia, by direct approach",0.05
chlamydophila psittaci igm,0.0
"atenolol+nifedipine 50 mg+20 mg (lab biogaran), capsule",0.05
Phenylpyruvate/Creatinine,0.05
Hemoglobin E/Hemoglobin.total,0.05
cd38+,0.0
anal wound suture without repair of the external anal sphincter muscle,0.0
cvs spectravite advanced tab,0.0
consult / referral to nephrology,0.25
accu-chek,0.2
nerve block infusion check,0.05
"assault by other specified means, initial encounter",0.0
collagen-adp cartridge,0.0
nomenclature 8,0.0
"emicizumab 30 mg (hemlibra), inj sol, vial 1 ml",0.05
alpha-galactosidase-white blood cell count,0.0
ige allergen cor a 14,0.05
factor 2,0.0
other ph,0.05
6-acetylmorphine liquid chromatography mass spectrometry,0.0
unable to collect test 3,0.0
urine leukocyte esterase test,0.1
citrate,0.0
intranasal polypectomy,0.0
"progesterone, duke fertility clinic",0.0
manual reduction of paraphimosis,0.0
mental-behavioral disorders: tobacco - other disorders,0.05
"joint crystals, shape",0.0
glutamine sg,0.1
"flubendazole - fluvermal, 2% oral suspension",0.0
total carbon dioxide calculated,0.05
assault by other specified means - unspecified place,0.0
sodium sulfate,0.0
mutation 3,0.0
culture time,0.0
"mobilizing release of the knee joint by arthroscopy or arthrotomy, with complete release of the quadriceps",0.0
therapeutic infiltration of the median nerve in the carpal tunnel,0.05
intra cranial pressure alarm - low,0.0
stroke volume (sv nicom),0.05
"superficial nerve trunk anesthetic infiltration with diagnostic and prognostic evaluation, with electrical stimulodetection",0.05
pigweed common ab.ige.rast class,0.0
chlorine,0.0
atrophy of female genital tract,0.05
open reduction and internal fixation of fronto-naso-maxillary fracture via facial approach,0.0
suture or repair of the capsuloligamentous apparatus of a metacarpophalangeal joint,0.0
diphenhydramine,0.0
spermatozoa count in urine per high power field,0.0
"vertebral laminectomy with exploration of intradural contents and dural plasty, via posterior or posterolateral approach",0.0
tissue oxygen partial pressure,0.05
"anatomopathological examination of a resection specimen of an anatomical structure, without examination of margins or re-excision",0.0
serum protein electrophoresis total protein,0.1
subtractive osteoplasty of the alveolar ridge on a sector of 4 to 6 teeth,0.0
"osteosynthesis and/or facial suspension for le fort i type occlusofacial fracture, by direct approach",0.0
spot urine creatinine concentration,0.1
urinary ph,0.1
"neonatal cerebral infarction, right side of brain",0.05
lactobacillus acidophilus and bulgaricus,0.01
presence of left artificial shoulder joint,0.0
liver donor,0.0
human metapneumovirus rna,0.0
placement of a coronoradicular infrastructure [inlay core] under a crown or a bridge abutment with limited direct agreement,0.0
"porphyrins, fract, random urine",0.05
"Rat epithelium, serum proteins + urine proteins IgE",0.05
"excision of 1 to 3 polyps less than 1cm in diameter from the colon and/or rectum, by rectosigmoidoscopy or partial colonoscopy",0.0
neutrophil cytoplasmic ab.perinuclear.atypical,0.05
red blood cell agglutination,0.05
resting myocardial perfusion scintigraphy with electrocardiogram synchronization,0.05
wasp venom i3,0.0
basophils percentage,0.05
prot relev cnd1,0.0
isoniazid / rifampin,0.0
"selective or superselective embolization of an upper limb artery, by transcutaneous arterial route",0.05
biological validation,0.05
strongyloides sp igg,0.0
sex binding protein sbp,0.0
transfontanellar doppler ultrasonography of intracranial vessels,0.05
"family history of malignant neoplasm, bladder",0.0
p2y12 (pru),0.0
n. gonorrhoeae pcr in liquid media,0.0
"fall from moving wheelchair (powered), subsequent encounter",0.05
"aftercare following surgery of the circulatory system, nec",0.0
sudden infant death syndrome (sids),0.0
pala154thr,0.0
batch number,0.0
transcatheter superselective embolization of a digestive artery,0.0
"spinal cord stimulation electrode removal, by direct approach",0.0
pilocarpine,0.05
terbutaline,0.0
round cells,0.0
spermatozoa motile,0.0
direct debit,0.0
vagisil_cream_30_gm,0.0
dpb1*,0.1
